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SUMMARY 
Stress urinary incontinence (SUI) and pelvic organ prolapse (POP) are 
both manifestations of pelvic floor dysfunction and represent major health 
problems for the female population. These conditions may affect women as 
separate or coinciding entities. Both conditions have surgery as a treatment 
option, and both are diagnosed based on objective findings. However, the 
decision for using surgical treatment options relies heavily on the patient’s 
subjective symptoms. As surgery is symptom dependent and not based on a 
life-saving need, the patients should be offered surgical treatment methods that 
have acceptable long-term outcomes with few complications, few unwanted 
short- and long-term effects and low re-operation rates.  
Retropubic tension-free vaginal tape (TVT) was introduced in 1996 as a 
new and innovative surgical approach in the treatment of stress urinary 
incontinence (SUI). The procedure has later also been applied to women with 
mixed urinary incontinence (MUI) and women with a low-pressure urethra. 
The short-term results, and short-term complication rates of the TVT 
procedure have been well documented, but the long-term outcomes for the 
whole surgically treated population are less known.   
De novo postoperative stress urinary incontinence (POSUI) following 
the repair of pelvic organ prolapse (POP) in previously continent women is a 
clinical challenge. The exact incidence is unknown, as few non-intervention 
studies have been conducted. TVT is often used when previously continent 
women need additional incontinence surgery some time after POP repair due 
to POSUI. Offering an incontinence procedure only to those that develop 
POSUI after POP surgery is often referred to as a “two-step” approach. 
However, the percentage of preoperatively continent POP women needing 
additional incontinence surgery after POP repair is largely unknown. 
Performing a “one-step” approach in which TVT is added as a prophylactic 
procedure to continent women undergoing POP surgery is advocated by some 
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surgeons, but remains controversial. The extra procedure has the risk of adding 
greater morbidity to the patient than the condition it is meant to prevent. For 
that reason, some surgeons have recommended a “selective one-step” 
approach. By this approach, TVT is added as a prophylactic anti-incontinence 
procedure only to women believed to have an increased risk of POSUI. 
Selecting these high-risk women is based on occult incontinence (OI) being 
diagnosed before surgery. Preoperative diagnosed OI has long been accepted 
as a predictor (or test marker) for identifying continent women at risk of 
POSUI. OI is clinically diagnosed when a continent woman with POP displays 
stress urinary leakage on provocation testing that mimics the POP repair. 
Using OI as a risk marker is based on the assumption that there is an 
association between OI and POSUI. This is, however, poorly investigated. 
There is to date no standardized diagnostic criteria for OI, which possibly 
explains the large variations in the reported prevalence with different test 
methods. The diagnostic accuracy and true predictive value of OI as a 
predictor of POSUI is therefore mostly unknown. 
The main aims of this PhD thesis were as follows. First we aimed at 
revealing the true long-term (10-year) efficacy of the TVT procedure for all 
patients undergoing the procedure (Paper I). We also wanted to explore any 
differences in TVT failure rates on the basis of individual preoperative and 
operative clinical factors such as concomitant POP surgery (Paper II). 
Secondly, we wanted to investigate the association between occult 
incontinence (OI) and postoperative stress urinary incontinence (POSUI) after 
POP surgery (Paper III). Lastly, we wanted to evaluate the test-performance of 
occult incontinence as predictor for individual women later developing POSUI 
(Paper III). 
For evaluating the long-term (10-year) efficacy of the retropubic TVT 
procedure, we invited all women, still alive (n=542), that had been operated 
with the procedure in 1998, 1999 and 2000 at 4 gynaecological departments 
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within the South-Eastern Region of Norway back for a clinical 10-year follow-
up consultation (the TENT study). Those unable to attend were asked to 
undergo a structured telephone interview. The outcome data collected at the 
10-year follow-up were merged with the preoperative, operative and 6-12 
months follow-up data stored in the Norwegian Female Incontinence Registry 
(NFIR).  
Logistic regression analyses were performed on two separate outcomes 
(subjective and objective 10-year failure rates) using additional patient data 
extracted from NFIR.  
The potential statistical association between occult incontinence (OI) 
and postoperative stress urinary incontinence (POSUI) after pelvic organ 
prolapse surgery, and the diagnostic accuracy (test performance) of OI testing, 
were evaluated in a prospective non-interventional observational study at the 
Department of Gynaecology at Oslo University Hospital. In this study 137 
continent women with POP were tested for OI before surgery and de novo 
POSUI after surgery. Four tests and three test combinations for OI were 
evaluated.  
This PhD thesis concludes that: 
• Retropubic tension-free vaginal tape has excellent cure rates 10 years after 
surgery for the total surgically treated population. Objective cure rate after 10 
years was 89.9 %, subjective cure rate 76.1 %, and 82.6 % of the patients 
stated that they were “very satisfied” with their surgery. Only 2.3 % had 
undergone repeat SUI surgery at the time of follow-up. Subjective voiding 
difficulties were reported by 22.8 %, the majority describing slow stream or 
intermittency. Other long-term unfavourable outcomes investigated were rare 
(Paper I). 
• Patient age ≥ 56 years at the time of surgery, mixed incontinence with a 
severe preoperative component of urgency incontinence symptoms and 
surgical complications all proved to be independent risk factors for long-term 
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failure (Paper II). Concomitant POP surgery was not an independent risk factor 
for long-term failure in this study. 
• There is a statistical significant positive association between occult 
incontinence (OI) and postoperative stress urinary incontinence (POSUI) 
(Paper III). However, even though this association was seemingly strong for 
one test and all test combinations with odds ratios (OR) from 6.8 to 9.0, all 
tests and test combinations investigated showed poor diagnostic accuracy (test 
performance) predicting the development of POSUI in individual women. We 
conclude that OI is a poor clinical marker for POSUI and that a “two-step” 
surgical approach is recommended (Paper III). 
 
The findings of the present PhD thesis will be used to optimize and 
individualize the patient counselling prior to both TVT and POP surgery. It 
will give women more accurate and realistic expectations regarding their long-
term outcome after TVT surgery based on individual clinical characteristics. It 
will hopefully reassure continent women with POP contemplating surgical 
reconstructions that the risk of developing POSUI is low, and for those few 
developing POSUI there is the possibility for correcting this later on (using a 
“two-step” surgical approach). As OI does not adequately identify women who 
would benefit from prophylactic anti-incontinence surgery at the time of POP 
surgery, there is currently no medical indication for time-consuming OI testing 
in ordinary clinical practice. 
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1. INTRODUCTION 
 
1.1 The Female Pelvic Floor 
 
The female pelvis is an anatomical and functional unit with many tasks 
beyond the mere support of pelvic organs. It comprises the bony pelvis, 
striated and smooth muscle fibres, connective tissues, nerves and vascular 
networks. These components integrate and play vital roles in the healthy 
normal pelvis. The striated muscular complex, called the levator ani muscle, 
constitutes (together with the coccygeus muscle) the floor of the pelvis. 
Standardized anatomical terminology now separates the levator ani muscle 
complex into three major components: the ileo-coccygeus, the pubo-coccygeus 
and the pubo-rectalis muscle (1). As the pubo-coccygeus for the most part 
inserts its fibers into the walls of the vagina and anorectum, not the coccyx, the 
term pubo-visceralis is favoured by some to comprise the pubo-coccygeus and 
the pubo-rectalis muscle (1). The pelvic connective tissues are structured into a 
fascial sheet (endopelvic fascia) covering the pelvic floor muscles, condensing 
around the organs and forming ligaments connecting the pelvic organs to the 
bony pelvis (2;3). Smooth muscle fibres also play a vital role in the 
maintenance of normal pelvic strength, particularly in the anterior vaginal wall 
in which they are organised in tight bundles oriented in a circular and 
longitudinal order (4). A decrease in the overall amount of these fibres into 
fewer, smaller and disorganized bundles has been associated with anterior 
compartment pelvic organ prolapse (POP) (4;5). Additionally, the vascular 
network around the urethra are known to contribute to female continence (6;7). 
Disruptions of normal function, called dysfunctions of the female pelvic 
floor, may affect micturition, defecation and sexual function. It may be due to 
a decline in mechanical strength or disruptions in the finely tuned functional 
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interactions between the various components (vascular networks, neuronal 
reflex pathways, connective tissue, striated and smooth muscles) that constitute 
the pelvic floor unit. Failure of one or more of these functional and structural 
elements (following trauma, disease or aging) may in some instances start a 
chain of events leading to a variety of dysfunctional manifestations. Known 
factors associated with pelvic floor dysfunctions are muscle trauma (8;9), 
connective tissue remodelling (10-12), changes in smooth muscle fibres (4;5), 
changes in the vascular network (6;7) and anatomical modifications due to 
pelvic floor surgery (13;14).  
The two most prevalent dysfunctions of the female pelvis are stress 
urinary incontinence (SUI) and pelvic organ prolapse (POP). Both are 
conditions gravely diminishing the quality of life for many women (15;16). 
Both conditions have surgery as one of the treatment options (further described 
in sections 1.3 and 1.5). As this surgery is performed due to symptoms and not 
based on a life-saving need, it is of importance that the surgical treatment 
options demonstrate acceptable long-term results and fewest possible surgical 
complications, fewest possible short and long-term unwanted effects and low 
re-operation rates. The lifetime risk for a woman having to undergo surgery for 
POP or urinary incontinence (UI) by the age of 80 has been found to be 11 % 
(17;18).  
 
1.2 Urinary Incontinence 
 
Urinary incontinence (UI) is defined, in the joint terminology report 
from the International Urogynecological Association (IUGA) and International 
Continence Society (ICS), as the complaint of any involuntary leakage of urine 
(19). It may be divided into the main categories of stress urinary incontinence 
(SUI), mixed urinary incontinence (MUI) and urgency urinary incontinence 
(UUI). As previously mentioned, treatment of urinary incontinence is symptom 
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dependent and not based on a life-saving need. Therefore, finding the proper 
management often needs a further characterization in which not only type of 
incontinence, but frequency and severity, precipitating factors, social impact, 
effect on hygiene and quality of life is considered (20). 
Urinary leakage is highly prevalent and found to affect one in four 
women in a large community-based epidemiological Norwegian survey (The 
Norwegian EPICONT Study) (21). The prevalence and the severity are, in 
several studies, demonstrated to increase with age (21;22). There seems to be 
an increase in prevalence unto middle age, before falling a little between 50 
and 70 years, after which it again shows a steady increase, except for stress 
urinary incontinence (SUI) peaking at the time of menopause (21). 
Stress urinary incontinence (SUI) is defined by the IUGA/ICS as the 
complaint of involuntary loss of urine on effort or physical exertion (e.g. 
sporting activities), or on sneezing or coughing (19). Urodynamic stress 
incontinence may be noted during filling cystometry, and is then defined as the 
involuntary leakage of urine associated with increased intra-abdominal 
pressure, in the absence of a detrusor contraction (19;23). SUI is the most 
prevalent of the different types of urinary incontinence affecting 10 to 39 % of 
all women, MUI being the next most common affecting 7.5 to 25 % and 
isolated UUI affecting only 1-7 %, as reviewed by the 5th International 
Consultation on Incontinence (24). SUI was found to comprise 50 % of all 
women with urinary incontinence in the Norwegian EPICONT study surveying 
Norwegian women between 1995 and 1997, with urgency urinary incontinence 
(UUI) accounting for 11 % and mixed urinary incontinence (MUI) accounting 
for 36 % (21). Women with SUI demonstrate, on evaluation, a spectrum of 
urethral characteristics from a highly mobile urethra with a normal or low 
urethral closure pressure to an immobile urethra with a normal or low urethral 
closure pressure.  
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The risk factors for SUI are older age (21;25), pregnancy (26;27), 
vaginal delivery  (25-27), multiparity (25;28), previous pelvic surgery (13;25), 
menopausal status (25) and repetitive stress on the pelvic floor from 
constipation (25), chronic cough (respiratory disease) (25) and obesity (25-27). 
In the younger women, loss of urethral support due to trauma (vaginal 
delivery) and sphincter function seem to contribute equally to the cause of 
SUI, while later in life the declining sphincter function dominates (29). 
 UUI is defined by the IUGA/ICS terminology report as the complaint of 
involuntary loss of urine associated with urgency (19). It is often part of the 
overactive bladder syndrome (OAB) defined as urinary urgency, usually 
accompanied by frequency and nocturia, with (OAB wet) or without (OAB 
dry) UUI, in the absence of urinary tract infection or other obvious pathology 
(19). OAB can be diagnosed on symptoms alone, but may be supported by the 
occurrence of involuntary detrusor contractions during a filling cystometry. 
The prevalence of UUI symptoms increases with age (21;30-33).  
MUI is the coexistence of stress and urgency urinary incontinence and is 
defined by the IUGA/ICS terminology report as the complaint of involuntary 
loss of urine associated with urgency and also with effort or physical exertion 
or on sneezing or coughing (19). The prevalence of MUI symptoms also 
increases with age (21;33).  
Hereditary genetic factors probably predispose for all incontinence types 
(34-36). For SUI, there is also a substantial influence of environmental factors 
such as childbirth, obesity and the process of aging (34).    
 
1.3 Surgical management of Urinary Incontinence  
 
Different surgical procedures as management of Stress Urinary 
Incontinence (SUI) have been offered to women in the developed world for 
approximately 100 years. Kelly described the open vesical neck in 1912 and 
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the successful results from an operation involving plication of the vesical neck 
(37). In 1949 a new innovative approach focusing on the restoration of the 
posterior vesico-urethral angle was described, called the Marshall, Marchetti, 
Krantz operation (38). This again led to a new area brought further by a 
publication from John Burch in 1961 describing an abdominal procedure, first 
performed in 1958 (39). He demonstrated that suturing the perivaginal tissue to 
the arcus tendineus fascia pelvis could restore continence, and explained the 
results as a restoration of normal position and support to the vesico-urethral 
segment. He later changed the technique finding the iliopectinal ligament 
(Cooper’s ligament) on the superior ramus of the pubic bone to be a more 
secure site for suture anchoring.  
In order to minimize the surgical trauma, several minimally invasive 
methods for suspending the vesico-urethral segment of the vagina were 
developed. These, often referred to as transvaginal needle suspensions or 
needle urethropexies, involved transvaginal placement of sutures anchoring the 
suburethral endopelvic fascia to the rectus fascia or pelvic bone. One of these 
procedures was the Stamey’s abdominovaginal needle colposuspension 
(40;41). Other methods of suspending the vesico-urethral segment of the 
vagina evolving over the years are the pubovaginal slings, traditionally using 
autologous fascia obtained from the abdominal rectus fascia or tensor fascia 
lata (42;43). Also allo- and xenografts have been used as sling material (44). 
All of these methods, with the exception of the Burch procedure, are presently 
in little use. The pubovaginal slings are used on rare occasions in some centres, 
but reserved for the difficult cases of intrinsic sphincter deficiency (particularly 
without hypermobility), simultaneous urethral reconstruction (diverticulectomy 
or fistula repair) or in patients who have undergone previously failed synthetic 
mid-urethral sling procedures, as recently reviewed by Hou (45). The Burch 
procedure has later been modified to be done by conventional laparoscopy or 
robot-assisted laparoscopy, but is now replaced by mid-urthral slings in most 
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urogynaecological centres. Until the mid-urethral slings were introduced in the 
nineties, the Burch colposuspension was considered the most successful 
surgery for genuine SUI, although the scientific evidence was weak (46). It 
was known as the “gold standard” to which all later surgical methods had to be 
compared. However, the long-term results of the procedure have later been 
found somewhat disappointing (47).  
In 1990 Ulmsten and Petros proposed a new theory called “the integral 
theory of female urinary incontinence” (48). They built further on the growing 
amount of evidence pointing towards the importance of supporting the mid-
urethra rather than the vesico-urethral junction in the female continence 
mechanism. “The integral theory” explained both stress and urgency symptoms 
as deriving from a laxity of the vagina caused by defects within the vaginal 
wall itself or its supporting structures (ligaments, muscles and their connective 
tissue insertions) (48;49). Essential to this theory was the understanding that 
the vagina has two distinct anatomical segments, which are being pulled in 
opposite directions during straining against a connective tissue structure called 
the pubo-urethral ligament (48;49). The anterior segment of the vagina, called 
the “hammock”, contains the lower 2/3 of the urethra with the pubo-urethral 
ligament and ascends with an angle of 45 degrees to the horizontal. During 
straining the anterior part of the pubo-visceralis muscle stretches this part of 
the vagina forwards (1st urethral closure mechanism) whilst at the same time 
the proximal part of the vagina, the “supralevator vagina”, with its more 
horizontal positioning, is being pulled backwards by posterior fibres of the 
pubo-visceralis muscle (2nd closure mechanism). According to this theory, such 
a simultaneous movement in opposite directions, resulting in the closing of 
urethra from behind against the pubo-urethral ligament, is an essential 
supplement to the sphincteric function in order to maintain continence in the 
female urethra (48;49). The theory was met with scepticism in the beginning, 
until the tension-free vaginal tape (TVT) was introduced in 1996 and quickly 
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produced remarkable results (50). The original tension-free vaginal tape (TVT) 
is a synthetic mesh sling inserted vaginally and placed retropubically on each 
side of the urethra through the urogenital diaphragm traversing the space of 
Retzius to the abdominal skin. This sling then replaces the missing function of 
the pubo-urethral ligament and provides support to the mid-urethra at times of 
elevated intra-abdominal pressure (such as cough and straining). In theory, the 
sling exerts no tension to the urethra at rest (50). This technique has later been 
modified in several ways, the most noteworthy being the alternative insertion 
via the trans-obturator opening. The synthetic material currently used by all 
mid-urethral slings on the market is the monofilament macroporous Type-1 
polypropylene.   
Mid-urethral slings are regarded as the new “gold standard” in surgical 
treatment of SUI today (51). It is also increasingly used in the treatment of 
MUI, especially in women where the MUI is dominated by stress urinary 
symptoms (52;53), and in patients with a low-pressure urethra (54;55).  
 
 
1.4 Pelvic Organ Prolapse 
 
 
 Pelvic organ prolapse (POP) is defined, in the joint terminology report 
from IUGA/ICS, as the descent of one or more of the following vaginal 
compartments; anterior vaginal wall, posterior vaginal wall, the uterus (cervix) 
or the apex of the vagina (vaginal vault or cuff scar after hysterectomy) (19). It 
may entail the descent of bladder, rectum, uterus or a peritoneal sack with or 
without abdominal content (e.g. small intestines) through the natural opening 
in the pelvic floor through which the urethra and vagina traverse. The 
examination of POP is, in Norway, performed with the woman positioned in 
the semi-lithotomy position, but it may also be performed in the left lateral 
(Sims), supine or standing position, if this better demonstrates the POP. The 
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POP should be staged according to the Pelvic Organ Prolapse Quantification 
(POP-Q) system (19;56).  
The POP-Q stages are (19;56): 
Stage 0: No prolapse is demonstrated. 
Stage I: Most distal portion of the prolapse is more than 1 cm above the 
level of the hymen. 
Stage II: Most distal portion of the prolapse is 1 cm or less proximal to or 
distal to the plane of the hymen. 
Stage III: The most distal portion of the prolapse is more than 1 cm below 
the plane of the hymen. 
Stage IV: Complete eversion of the total length of the lower genital tract.  
 
Each of the three vaginal compartments (anterior- mid-and posterior) is staged 
separately. 
The most common symptoms of POP are the complaint of vaginal 
bulging, increased heaviness, bleeding and discharge, splinting/digitations, 
sexual dysfunction and low backache (19). The presence of a prolapse should 
always be considered together with relevant POP symptoms, as treatment is 
symptom dependent. However, there is not always a clear correlation between 
subjective symptoms and the objective stage of the prolapse, but a good 
correlation is more commonly present when the prolapse is at the level of the 
hymen or beyond (57).  
 POP is common. The prevalence of POP based on the sensation of a 
mass bulging into the vagina has been found ranging from 5 % to 10 % as 
reviewed by the 5th International Consultation on Incontinence (24). However, 
POP has a much higher prevalence when based solely on anatomical 
examination regardless of symptoms as demonstrated in a Swedish population 
of women from 20 to 59 years of age where the overall prevalence of POP was 
30.8 % (58). An anterior vaginal compartment prolapse is the most common 
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form of prolapse followed by prolapse in the posterior compartment as the 
second most common and a mid-compartment (apical) prolapse as the least 
common (17;59;60). POP may commonly involve more than one compartment 
(17;59). Prevalence also seems to be race dependent as two studies have found 
that Hispanic women have the highest prevalence and African American 
women the lowest after controlling for multiple other factors (59;61). The 
surgery rate for Caucasian has also been found higher (3 times) than for 
African Americans (62). The prevalence has in a cross-sectional study from the 
US been found to increase with age (63). The lifetime risk of any American 
woman having to undergo at least one surgery for either POP or UI by the time 
she is 80 years of age has been estimated to 11 % (17;18). However, in a more 
recent study by Smith et al, the lifetime risk of undergoing POP surgery alone 
in Western Australia was reported to be 19 % (64). This might be suggestive of 
local differences in indications for surgery around the world. The risk of 
having to undergo POP surgery has, however, uniformly been shown to 
increase with advancing age (17;62;64;65).   
The etiology of POP is poorly understood and probably multi-factorial. 
The most accepted risk factors are vaginal childbirth (61;66-68), increasing 
body-mass index (59;60;66;69) and advancing age (59;60;70). Additionally 
repetitive strain on the pelvic floor due to heavy lifting (71;72), genetic factors 
(34;73), previous hysterectomy (14;70;74;75), previous POP surgery (70), 
obstetrics factors such as increasing parity (59;74;76), operative vaginal birth 
(68;69), being younger at first delivery (69)  and even pregnancy itself 
(although less reliably associated) increase the risk for POP (77;78). 
There is seldom severe morbidity associated with POP, when adequately 
diagnosed and treated, and the surgery is therefore always symptom dependent 
and rarely based on a life-saving need. However, as POP heavily impacts the 
quality of life and sexual function for many women (15;79), reconstructive 
surgical POP repair is offered when conservative treatment has proven 
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unsuccessful. 
 
1.5 Pelvic Organ Prolapse surgery 
 
 Surgical treatment is often offered women with symptomatic pelvic 
organ prolapse (POP) when pessary treatment or pelvic floor muscle training 
fails, or the women decline these conservative measures. POP surgery can be 
reconstructive or obliterative, the latter performed in elderly women without a 
wish for future vaginal intercourse. Reconstructive POP repair aims to correct 
the prolapse and thereby relieve the associated symptoms while at the same 
time maintaining the opportunity for vaginal intercourse. POP surgery can be 
performed either by the abdominal or the vaginal route. The reconstructive 
techniques either utilise the patient’s own tissues (native tissue repair) or 
supplement the surgery with meshes made from biologic or synthetic 
materials. Epidemiologic studies from the United States have shown that the 
majority of POP surgeries are performed by the vaginal route (17;18;62;80). 
Since women with symptomatic POP often present themselves with a prolapse 
in more than one compartment (17;59), the reconstructive surgery typically 
involves a combination of re-suspension of the anterior, apical or posterior 
compartments. 
 
1.5.1 Stress urinary incontinence on prolapse reduction (Occult 
incontinence) 
 “Stress urinary incontinence on prolapse reduction” is the term currently 
suggested in the joint IUGA/ICS terminology report for stress urinary 
incontinence only observed after the reduction of a co-existent prolapse (19). 
The prolapse patient has otherwise no symptoms or signs of incontinence when 
the prolapse is present. This phenomenon was previously known by a variety 
of names such as “occult incontinence”, “latent incontinence”, “masked 
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incontinence”, “potential incontinence”, “hidden incontinence” and “iatrogenic 
incontinence”. For reasons further elaborated under section 5.1.2, this thesis 
uses the term “occult incontinence” (OI). OI is clinically diagnosed when a 
continent woman with POP displays stress urinary leakage during provocation 
testing. The provocation tests have the objective of mimicking the result after 
POP repair. OI has long been thought of as a risk-marker for identifying 
women at high risk of developing POSUI after POP surgery (81;82). The 
mechanism(s) by which a prolapse may mask SUI, and why the SUI would 
reveal itself as OI during preoperative testing and subsequently as POSUI after 
POP repair, is not fully understood. A kinking of the urethra or a direct 
compression effect by the descending prolapse are suggested as explanations 
of how some POP patients maintains continence prior to prolapse reduction 
(83-85). A correction of the anatomy at testing and after POP surgery is 
suggested to decrease resistance to the urethra, unmasking an intrinsic 
sphincter deficiency in some patients, and thereby reveal itself as SUI (86;87).  
However, the accuracy of OI as a risk-marker for POSUI is poorly 
investigated. It has repeatedly been shown that continent women with POP, 
having no demonstrable occult incontinence, also develops POSUI (false 
negatives) (88-90), and several studies have also demonstrated that a large 
proportion of continent POP women with demonstrable occult incontinence 
never develops POSUI (false positives) (88-90). These findings have been 
suggested by some to be due to a lack of an optimal OI test today, and when 
this test is eventually discovered in the future, all patients at risk of developing 
POSUI will be identified during preoperative OI testing (91). 
There is to date no standardisation on how best to test for OI. A 
multitude of tests are described in the literature differing in mode of prolapse 
reduction (using pessary, vaginal packing, manual/digital repositioning, 
forceps, speculum etc), type of provocation/stress (Valsalva, cough, exercise 
regimens or daily life activities), positioning during testing (supine, standing, 
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sitting, lithothomy, semi-lithotomy) and bladder volumes during testing 
(83;84;86-89;92-102).   
 
1.5.2 Postoperative stress urinary incontinence (POSUI) 
 Performing pelvic organ prolapse (POP) surgery carries with it the risk 
of permanently changing the patient’s bladder function. According to an 
updated review of randomized controlled trials by the Cochrane Collaboration, 
new overactive bladder symptoms (OAB) were noted in 12 % and new voiding 
dysfunction in 9 % following POP surgery (103). However, de novo 
postoperative stress urinary incontinence (POSUI) is the most controversial of 
these unwanted effects of POP surgery, as adding a prophylactic anti-
incontinence procedure might possibly prevent it. POSUI has, in the literature, 
a reported incidence ranging from 11- 44 % (89;101;103-105). Although the 
data are limited and the patient groups may be biased, there seems to be a 
higher risk of POSUI in women undergoing POP surgery that includes mesh in 
the anterior vaginal wall, as compared to the native tissue repair techniques, 
possibly due to an overcorrection of the anterior vaginal wall (106;107). 
Several studies have demonstrated a reduced risk for POSUI both in women 
with preoperative OI (88;97;101;102) and in women without preoperative OI 
(88;101) if a prophylactic anti-incontinence procedure is added to the POP 
surgery in continent POP women. Furthermore, in a meta-analysis from the 
Cochrane Collaboration of studies randomising patients with POP and occult 
incontinence to either POP surgery with prophylactic anti-incontinence surgery 
or POP surgery alone, a significantly higher rate of POSUI was seen in women 
who did not receive prophylactic anti-incontinence surgery (43 % vs 19 %) 
(103).  
However, it is of concern that even when an anti-incontinence procedure 
is used as a prophylactic procedure against POSUI, one in five (19 %) still 
ends up with the unwanted outcome (POSUI) (103). The occurrence of 
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POSUI, even after prophylactic anti-incontinence surgery has been performed 
in OI women, has been demonstrated in several large studies (101;105). Lastly, 
adding to the scepticism of performing a prophylactic anti-incontinence 
procedure in prolapse women with OI, comes the potentially increased 
morbidity from the additional procedure. The added morbidity may include 
bladder outlet obstructions, bladder perforations, haematomas, de novo OAB 
symptoms and, if a mid-urethral sling with synthetic mesh is used, vaginal 
mucosa mesh extrusions (101;108;109).  
 
1.5.3 The “One-step” or “Two-step” approach to POP surgery? 
 There is today a great debate in the urogynaecological field whether or 
not concomitant POP and SUI surgery for women with coinciding POP and 
manifest SUI should be performed. According to a recent update from the 
Cochrane Collaboration, no clear recommendations can be made from the 
available clinical evidence (103). The controversy is even greater when 
considering the use of SUI surgery as a concomitant prophylactic procedure in 
continent women undergoing POP surgery (91;110). There are different 
approaches to this question in the literature supporting various strategies, none 
agreed upon by all clinicians or researchers. Practice vary from those 
recommending prophylactic anti-incontinence procedure (such as the 
retropubic TVT) in all patients undergoing surgery for POP (the “one-step” 
approach) regardless of preoperative continence status (91) to those 
recommending to perform a prophylactic anti-incontinence procedure in none, 
but rather wait and see which patients develops SUI symptoms after the POP 
surgery (the “two-step” approach) (110;111). Others again recommend the use 
of prophylactic anti-incontinence procedures selectively in POP patients with 
preoperative occult incontinence (the “selective one-step” approach) 
(102;112;113).   
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The main argument for adding a prophylactic anti-incontinence 
procedure to all women undergoing POP surgery, regardless of their OI status 
(the “one-step” approach), is first of all that it is a simple algorithm that will 
not miss any patient at risk for developing POSUI. Surgeons favouring this 
approach argue that today’s tests for OI has low predictability with a high rate 
of false positives and false negatives and that the correlation between OI and 
POSUI is disrupted by an anti-incontinence effect from the POP surgery itself 
(91). The curative effect of the POP surgery itself, such as an anterior 
colporrhaphy, is inferior (and mostly abandoned as treatment of manifest SUI) 
to the current methods of incontinence surgery. POP patients not receiving 
concomitant incontinence surgery are therefore, in their opinion, “robbed” of 
the most optimal incontinence procedures available. These surgeons often site 
the CARE study, demonstrating a reduced incidence of POSUI in all patients, 
not only OI women, if a prophylactic anti-incontinence surgery was added to 
the POP surgery (88). Also, the short-term cost for one rather than two surgical 
treatments (one vs two hospital stays and one vs two sick-leaves) may be less 
for the society and the patient.   
The surgeons favouring prophylactic anti-incontinence procedures only 
to continent women with OI (“selective one-step” approach) argue that there is 
a clear association between OI and POSUI evident from the reduction of 
POSUI seen when adding prophylactic anti-incontinence procedures to OI 
women only (102;112;113). Furthermore, a selective approach confines the 
added risk of unwanted effects from the incontinence procedure to the women 
most at risk for POSUI. It can also be argued that the direct cost related to the 
mesh used in the anti-continence surgery (TVT) would be avoided in a great 
many woman if the a “selective one-step” surgical approach was used. 
 The surgeons advocating never to perform prophylactic incontinent 
surgery to continent POP women at the time of surgery, but to reserve this to 
women actually developing bothersome POSUI (“two-step” approach) often 
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use the same argument as those favouring prophylactic incontinent surgery in 
all women, namely that predicting who will need later surgery for POSUI is an 
inexact science. This conservative approach has the obvious benefit of 
guaranteeing that no woman receives an unnecessary procedure since a 
concomitant POP and TVT operation always carries an added risk (101;109). 
However, there seems to be universal agreement among surgeons 
favouring all three options that preoperative counselling is essential, 
empowering women to participate in the decision-making considering both 
risks and benefits. If one is contemplating the use of a prophylactic anti-
incontinence procedure when undergoing POP repair, finding the right 
prophylactic procedure seems essential. This optimal procedure should add as 
little morbidity as possible to the POP procedure, have good long-term results 
and few long-term unwanted effects.  
Reliable cost-benefit analyses need to be performed regarding the “one-
step” approach, “selective one-step” approach or the “two-step” approach as, 
sadly, not only pure medical arguments impact the decision making for health 
care providers. Such analyses will differ significantly depending on type of 
health care system and the socioeconomic situation for the relevant patient 
group.  
 
1.6 The Norwegian Female Incontinence Registry (NFIR) 
 
 The Norwegian Female Incontinence Registry (NFIR) was started as a 
common database September 1st 1998, to which 23 gynaecologic departments 
in the beginning reported their preoperative, operative, 6-12 months 
postoperative and 3 years postoperative data (114). In 2013 the Registry was 
made a national quality database for female incontinence surgery data. The 
number of hospitals reporting to the national registry has over the last years 
been fairly constant around 30. At the present (October 2013), there are 29 
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departments reporting regularly to the NFIR out of 45 departments performing 
female incontinence surgeries in Norway. These 29 departments perform 83 % 
of all female incontinence surgeries in Norway (2012). The number of 
departments reporting to the NFIR is thought to increase as a consequence of 
the NFIR being given the role of a national quality registry.  
The NFIR operates under the Norwegian law on data protection with 
licence from the Norwegian Data Inspectorate and the Norwegian Health and 
Medicines Authority. It requires individual patient consent for the storage of 
de-identified patient data. It operates within the Norwegian Health Personnel 
Act § 26 and sends out yearly reports to contributing departments in which 
both the department and the individual surgeon is compared to a national 
average on numerous outcome measures (complication rates, patient 
satisfaction, objective results from postoperative incontinence testing). This 
way the data is continuously used to monitor, secure and improve the quality 
of the surgical procedures in addition to represent a great potential for 
research.  
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2. AIMS OF THE THESIS 
 
The long-term outcomes for all patients undergoing the retropubic 
tension-free vaginal tape procedure (TVT) as treatment for stress urinary 
incontinence (SUI) and mixed urinary incontinence (MUI) are not fully 
investigated. TVT is a relatively new incontinence procedure first implemented 
in clinical use in 1996. Whether concomitant POP surgery or other 
preoperative and operative clinical factors are risk factors for long-term failure 
is unknown. De novo postoperative stress urinary incontinence (POSUI) has 
long challenged surgeons performing pelvic organ prolapse (POP) repair 
regardless of surgical methods or surgical skills. It has been argued that adding 
a prophylactic anti-incontinence procedure, such as TVT, at the time of POP 
surgery would be an attractive approach in order to reduce the incidence of 
POSUI. Occult incontinence (OI) has been used as a test marker for identifying 
patients with high risk of developing POSUI, but the diagnostic accuracy (test 
performance) of such testing has not been fully investigated. 
The specific aims of this thesis were therefore to: 
1. Evaluate the long-term results after retropubic tension-free vaginal tape 
(TVT) procedure. 
2. Investigate potential preoperative and operative risk factors, such as 
concomitant POP surgery, for long-term failure of the retropubic TVT 
procedure.   
3. Investigate and measure the association between occult incontinence (OI) 
and postoperative stress urinary incontinence (POSUI) after POP surgery 
and evaluate the test performance of various tests for OI as predictor for 
POSUI after POP repair. 
 
 32 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 33 
3. MATERIAL AND METHODS 
 
3.1 Patient selection  
 
 The patients investigated in this PhD thesis consist of two separate 
patient populations; the ten-year follow-up after tension-free vaginal tape 
(TENT) study population and the postoperative stress urinary incontinence 
(POSUI) study population. 
 
3.1.1 The TENT study (Papers I and II)  
The women included in the TENT study (10-year follow-up after 
retropubic TVT procedure) form the basis for Papers I and II and were 
identified using the Norwegian Female Incontinence Registry (NFIR). This 
study was a multicentre study conducted at four Norwegian hospitals located 
in the South-Eastern region of Norway; Oslo University Hospital, Asker and 
Bærum Hospital, Vestfold Hospital and Østfold Hospital. All patients still 
alive 10 years after their TVT surgery at these hospitals were invited to a 
clinical follow-up consultation. Women unable to attend were offered a 
structured telephone interview. The same short-form urinary incontinence 
disease-specific questionnaire was used for both categories (se section 3.3) 
(115). The only inclusion criterion was that they had received a retropubic 
TVT in the time period September 1st 1998 (after the inception of the NFIR) 
through the year 2000 at one of the participating hospitals. The only exclusion 
criterion from the study was the inability to give informed consent due to 
reduced mental capacity. For the complete overview of recruitment and 
dropouts of the study participants, please see flowchart (Figure 1) in Paper I.  
This non-selected heterogeneous patient population consisted of women 
having received retropubic TVT either as primary or secondary treatment for 
SUI or MUI. The population included both women with hypermobility of the 
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urethra, low urethral closure pressure and women undergoing concomitant 
POP surgery. The surgeries at one of the participating hospitals (Oslo 
University Hospital) were performed at two separate locations during the study 
years (Aker University Hospital and Ullevål University Hospital). However, at 
the time of the 10-year follow-up, these two gynaecologic departments had 
been merged and re-located at Oslo University Hospital, location Ullevål. All 
the tension-free vaginal tapes (TVTs) used during the study years were from 
the same manufacturer (Ethicon Gynecare). A written informed consent was 
obtained from all participating women (included women undergoing telephone 
interview only). The data collected at the 10-year follow-up was merged with 
individual preoperative, operative and 6-12 months follow-up data previously 
stored in the NFIR. The NFIR also contains 3-year follow-up data for some 
patients. A 3-year follow-up is, however, not routinely performed at all 
participating hospitals and therefore contains a high degree of missing data. 
We therefore decided not to use these incomplete 3-year data in this study. 
To evaluate whether the women operated at the four study hospitals 
were representative of the national patient group, we compared the study group 
with the remaining women registered in the NFIR having undergone a TVT 
operation during the study years at other hospitals (n=747). The following 
preoperative variables were compared: age at the time of surgery, 24-hour pad-
test, pad stress test, post void residual volume (PVR), maximum flow rate 
(Qmax), maximum urethra closure pressure (MUCP), stress incontinence index 
scores and urgency incontinence index scores. 
 
3.1.2 The POSUI study (Paper III) 
 The women included, in the POSUI study, were recruited from one 
gynaecologic department only; Oslo University Hospital, location Ullevål. 
When the inclusion of patients for the study was commenced in 2007, Ullevål 
Hospital was an independent University Hospital. In 2008, however, Ullevål 
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University Hospital was merged with three other hospitals to form Oslo 
University Hospital, one of them with a small gynaecological department (The 
National Hospital, Rikshospitalet). As the study was already ongoing, no 
women treated for POP at this other location within Oslo University Hospital 
were included.  
All women scheduled for POP repair during a 3-year period (June 2007- 
June 2010) were assessed at the outpatient clinic for possible study 
participation. Inclusion criteria were any form of POP that needed surgical 
treatment. Exclusion criteria were a history of stress or urgency urinary 
incontinence, objective stress leakage during stress testing (without 
repositioning the prolapse), detrusor overactivity during urodynamic 
evaluation, inability to give informed consent and the lack of language skills in 
Norwegian or English. Women who had urgency without incontinence were 
allowed into the study. For the complete overview of recruitment and dropouts 
of the study participants, please see flowchart (Figure 1) in Paper III. Written 
informed consent was obtained from all participating women. 
To evaluate whether women participating in the POSUI study differed 
from the “average” woman undergoing POP surgery at our Department 
(selection bias), we did a post study comparison between study-patients and 
the total patient population undergoing POP surgery at our Department in the 
same time period. The following three variables were compared: surgical age, 
stage of prolapse and dominating POP compartment.  
 
3.2 The Norwegian Female Incontinence Registry (NFIR) 
 
 Data from the NFIR (see section 1.6) was used in the TENT study 
(Papers I and II). Ten-year follow-up data after TVT are not normally reported 
to the NFIR, and since this TENT follow-up study was not conducted at every 
hospitals reporting to the NFIR, the 10-year data could not be exported and 
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incorporated directly into the national database (NFIR). The latter would have 
allowed for a direct comparison with previously stored patient data. Instead, a 
separate Access database was created by the system developer working at the 
NFIR for the sole use of the participating TENT study hospitals. This allowed 
the 10-year data to be exported separately to the NFIR and merged with 
extracted individual patient data previously stored in the NFIR generating a 
study-database containing preoperative, operative, 6-12 months follow-up data, 
3-year follow-up data and 10-year follow-up data for each participating 
woman. The funding for this system development was by grants from the 
Nordic Urogynecologic Association (NUGA), the Norwegian Urodynamic 
Discussion Group (UDYDIG) and the Norwegian Female Incontinence 
Registry (NFIR).    
 
3.3 Questionnaire and objective evaluation tools   
 
3.3.1 Urinary Incontinence 
 All hospital departments reporting to the NFIR use a short-form urinary 
incontinence disease-specific questionnaire, see Appendix 1 (English) and 2 
(Norwegian) (115). This questionnaire has been validated in Norwegian and 
reports on the type of incontinence, the severity of symptoms and the quality of 
life (Qol) pre-and postoperatively in women undergoing surgeries for SUI or 
MUI (115). All the preoperative, operative, 6-12 months follow-up and 3-year 
follow-up data in the NFIR are based on this questionnaire. This questionnaire 
allows stratification of patients into stress and mixed incontinence by 
generating symptoms scores for stress and urgency incontinence symptoms 
resulting in a stress and urgency incontinence index (see below). Only women 
with an urgency incontinence index of 0 are regarded as having pure SUI. 
Based on this questionnaire (see Appendices 1 and 2), a stress 
incontinence index score ranging from 0 to 12 is constructed from questions 1, 
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2 and 3 in the questionnaire and similarly quantifies the degree of stress 
incontinence symptoms (higher scores represent worse symptoms). The 
relevant questions and response alternatives from Appendices 1 and 2 are as 
follows: 
 
Stress incontinence index:  
1. Do you leak urine?      Yes  no  not relevant 
when you cough       ⁯ ⁯ ⁯ 
when you sneeze       ⁯ ⁯ ⁯ 
when you laugh       ⁯ ⁯ ⁯ 
when you walk up or down in stairs    ⁯ ⁯ ⁯ 
when you raise from bed     ⁯ ⁯ ⁯   
when you lift heavy objects     ⁯ ⁯ ⁯ 
during physical activity (running to the catch the bus)   
⁯ ⁯ ⁯ 
during sports       ⁯ ⁯ ⁯  
during intercourse      ⁯ ⁯ ⁯ 
 
2. How often do you leak urine in relation to physical activity, when you 
laugh, cough or sneeze?  
⁯ never  
⁮ 1 – 4 times each month  
⁮ 1 – 6 times each week  
⁮ once per day  
⁮ more than once per day  
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3. How large is the amount of urine you usually leak during physical 
activity or when you laugh, cough or sneeze?  
⁮ nothing  
⁮ drops / moist underwear  
⁮ dripping / wet underwear  
⁮ running / passes through all your clothes  
⁮ running down your legs or down at the floor  
 
The stress incontinence index score is calculated in the NFIR as follows: 
• For question 1: Each “yes” marked by the woman, counts 1 and each 
“no” or “not relevant” counts 0. The summarised scores from question 1 
count in the stress index as follows: A summarised score of 0 is counted 
as 0. A summarised score of 1-3 is counted as 1. A summarised score of 
4-5 is counted as 2. A summarised score of 6-7 is counted as 3. A 
summarised score of 8-9 is counted as 4. Maximum score is 4 for 
question 1. 
• For questions 2 and 3: The alternatives are counted from top to bottom 
and gives the scores 0, 1, 2, 3 or 4. Maximum score is 4 for question 2 
and 4 for question 3. 
The maximum stress index score is 12 (4 + 4+ 4). 
 
 
Based on this questionnaire (see Appendices 1 and 2), an urgency 
incontinence index score ranging from 0 to 8 is constructed from questions 4 
and 5 in the questionnaire and similarly quantifies the degree of urgency 
incontinence symptoms (higher scores represent worse symptoms). The 
relevant questions and response alternatives from Appendices 1 and 2 are as 
follows: 
 
 39 
Urgency incontinence index:  
4. How often do you experience sudden and imperious need to void and 
urinary leakage before you reach the toilet?  
⁮ never  
⁮ 1 – 4 times per month  
⁮ 1 – 6 times per week  
⁮ once per day  
⁮ more than once per day  
 
5. How large is the amount of urine you usually leak when you experience 
sudden and imperious need to void and urinary leakage  
⁮ nothing  
⁮ drops / moist underwear  
⁮ dripping / wet underwear  
⁮ running / passes through all your clothes  
⁮ running down your legs or down at the floor  
 
The alternatives are counted from top to bottom and gives the scores 0, 1, 2, 3 
or 4. The maximum urgency incontinence index score is 8 (4+4). 
 
The quality of life index score ranges from 0 to 16 and is constructed 
from questions 7, 9, 10 and 12 in the questionnaire (higher scores represent 
worse quality of life), see Appendices 1 and 2.  
 
Quality of life index:  
 
7. How many incontinence pads do you use?  
⁮ none       ⁮ 1 – 3 per week ⁮ 4 – 6 per week       ⁮ 1 – 4 per day    
⁮ more than 4 per day  
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9. How often do you avoid activities (for example a hobby, physical 
training or going out) because you are afraid of leaking urine?  
⁮ never   ⁮ seldom  ⁮ sometimes  ⁮ often   ⁮ always  
 
10. Do you avoid places and situations where you are aware of that a toilet 
is not easily available?  
⁮ never   ⁮ seldom  ⁮ sometimes  ⁮ often   ⁮ always 
 
12. Does your urinary leakage influence   
  yes   no  not relevant  
your vacation?         ⁮  ⁮  ⁮ 
your family life?         ⁮  ⁮  ⁮ 
your social life (going out, meeting friends)?  ⁮  ⁮  ⁮ 
your sleep?          ⁮  ⁮  ⁮ 
 
For the construction of the Quality of life index, the alternatives for the 
questions 7 and 9-10 count from left toward right and give the scores 0, 1, 2, 3 
or 4.  For question 12, a “yes” counts 1, whereas “no” or “not relevant” counts 
0. The maximum quality of life index is 16 (4+ 4+ 4+ 4). 
 
The same NFIR questionnaire was used for the subjective data in all 
three papers. For the 10-year follow-up data after TVT (Papers I and II), we 
added three supplemental questions that were not validated; 
1. How would you characterize the effect of the operation on your current 
leakage situation? (Choices given: “cured”, “better”, “unchanged” or 
“worse”) 
2. Have you had the feeling that it is difficult to empty your bladder after 
the operation? If yes, please describe in detail. 
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3. Has it been persistently painful to empty your bladder after the 
operation? 
If the response to question 2 was yes, the patients detailed descriptions 
were classified using the terminology of voiding symptoms standardized in 
ICS/IUGA joint report (19) into the following groups: “slow stream or 
intermittency”, “position-dependent micturition”, “need to immediately re-
void”, “the feeling of incomplete bladder emptying”, “straining to void” and 
“hesitancy”. For this study we also added two response options: “more than 
one of the above”, and “other” (meaning the answers could not be classified 
into any of the above). 
For reasons elaborated under section 5.1.2, we did not use the Qol index in any 
of the papers constituting this thesis. 
 A reproducible cough/jump pad stress test is a routine part of the 
preoperative evaluation before TVT surgery and is also performed at 
subsequent follow-ups to quantify stress urinary leakage (116). The results 
from this test are routinely reported to the NFIR. In order to compare the 10-
year TVT data (Papers I and II) with objective leakage data previously stored 
in the NFIR, this test was also chosen as the objective test at the 10-year 
follow-up. It consists of pad weighing after 20 jumping jacks on the spot and 
three forceful coughs in the standing position with a standard 300 ml bladder 
volume. Women unable to perform the test were asked to do a modified 
version consisting of 10 coughs in the standing position, with the same bladder 
volume. The test-retest reliability of this test has been found sound when the 
leakage is visualized by the investigator (117). We extrapolated the test-retest 
reliability to be just as good when we allowed the patients to keep their 
undergarments on and instead verified the leakage by increased pad weight. 
The results from this test was also compared with the standardized pad stress 
test recorded in the NFIR as it was hypothesized that it would yield 
comparable results despite being slightly different tests.  
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In Paper III we used a visualized cough stress test (cough/Valsalva) in 
the semi-lithotomy position after retrograde bladder filling with 100 ml (first 
visit) and then 300 ml (second visit) to diagnose OI, and 300 ml (postoperative 
visit) to diagnose objective POSUI (see section 3.3.3). There were several 
reasons not to use the standardized pad stress test in this study, the main being 
the fact that these patients had no history of incontinence and were submitted 
to occult incontinence testing only. The standardized test has not normally 
been used when testing for OI in prolapse patients. Furthermore it was found 
too time-consuming when different types of barrier tests should be performed 
at the same visit. On the postoperative visit, we chose to repeat the test in the 
semi-lithotomy position with 300 ml bladder volume enabling best possible 
comparison to the preoperative tests. However, women complaining of 
bothersome symptoms at the postoperative visit and deemed being a potential 
candidate for surgical SUI treatment were given the full evaluation normally 
given before incontinence surgery, including a standardized pad stress test (2 
women). 
 
3.3.2 Pelvic Organ Prolapse 
 The assessment of pelvic organ prolapse in the POSUI study (Paper III) 
was done in the semi-lithotomic position during Valsalva and staged according 
to the Pelvic Organ Prolapse Quantification (POP-Q) system (23;56).  
 
3.3.3 Occult Incontinence 
 Occult incontinence (OI) is clinically diagnosed when a continent 
woman with POP displays stress urinary leakage during provocation testing 
whilst mimicking POP repair. In this thesis we have kept the term occult 
incontinence (OI) even though the new term used in the joint report from 
ICS/IUGA on the terminology for female pelvic floor dysfunction is stress 
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incontinence on prolapse reduction (19). The reasons for this decision is 
elaborated under section 5.1.2 
 In the POSUI study, we decided on four different provocation tests for 
diagnosing OI. All tests were performed on all women before surgery (Paper 
III). This was to enable evaluation of the diagnostic accuracy of both single 
tests and test combinations. Before testing, the bladder was emptied with a 
urinary catheter and the test volume of saline installed (see below). The 
women were asked to perform a Valsalva manoeuvre and cough vigorously in 
the semi-lithotomic position during Tests 1-3. Any visual leakage during either 
coughing or Valsalva was defined as a positive test. Test 4 was deemed 
positive if there was any subjective feeling of leakage. Test 3 was performed 
on a separate visit from Tests 1 and 2 (at the time of the preoperative 
urodynamic evaluation). Tests 1 through 3 were performed both with and 
without repositioning the prolapse. If there was visual leakage when tested 
without repositioning the prolapse, the patients were excluded, even if there 
was no history of incontinence. OI was diagnosed for the test combinations if 
there was leakage on minimum one of the tests. The prolapse repositioning 
methods (barriers) and the bladder test-volumes were as follows: 
 
Test 1: 100 ml bladder volumes.  
Prolapse manually (digitally) repositioned by examiner. 
 
Test 2: 100 ml bladder volumes.  
A pessary that optimally reduced the prolapse was fitted. 
 
Test 3: 300 ml bladder volumes.  
The pessary from Test 2 used. 
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Test 4:  
Continuous use of the pessary from Tests 2 and 3 for a minimum of 1 week. 
 
The test combinations were as follows:  
Test combination A (Tests 3 and 4). 
Test combination B (Tests 2, 3 and 4). 
Test combination C (Tests 1, 2, 3 and 4). 
 
3.4 Urodynamic evaluations 
 
 In Paper I the maximum urine flow rate (Qmax) was measured by free 
(spontaneous – no catheter) uroflowmetry. A catheter or bladder scanner 
(optional) was used to measure the post-void residual volumes (PVRs). The 
Qmax and PVRs are measured and continuously reported to the NFIR before 
surgery and at all subsequent follow-ups. The MUCPs stored in the NFIR and 
used in Paper II are identically measured at the four study hospitals by using an 
8 French (Ch) flexible polyurethane microtip dual sensor microtransducer 
catheter oriented with the sensors pointing to 3 o’clock and with a bladder 
volume of 300 ml. The rate of catheter withdrawal is 1 mm/s.  
In Paper III, a filling cystometry was performed to exclude patients with 
detrusor overactivity. An 8 French (Ch) flexible polyurethane microtip 
microtransducer catheter was placed in the bladder through the urethra and the 
intravesical pressure (P ves) was measured during filling. The abdominal 
pressure (P abd) was measured with a 10 French (Ch) intra-rectal balloon 
catheter. The retrograde filling of the bladder was performed through the 
microtip catheter at a rate of 25 ml/min. If there were any involuntary detrusor 
contractions (detrusor overactivity) during the filling-phase, the patients were 
excluded. 
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3.5 Outcome measures 
 
3.5.1 The TENT study (Papers I and II) 
 Primary objective outcomes in Paper I were cure rate, failure rate and re-
operation rate. Failure rate was also the objective outcome in Paper II. Cure 
rate was defined as no increase in pad weight (0 g) during a cough/jump pad 
stress test or the modified version as described in 3.3.1. Failure rate was 
defined as any increase in pad weight (≥ 1g) performing these tests or having 
had repeat surgery for SUI in the 10-year follow-up period. Re-operation rate 
was defined as any new surgeries for SUI (including periurethral bulking 
agents). 
 Primary subjective outcomes in Paper I were treatment satisfaction rate, 
cure rate, improved rate and failure rate. Failure rate was also used as the 
subjective outcome in Paper II. Treatment satisfaction rate was defined as the 
number of patients stating “very satisfied” when given the following choices in 
the validated questionnaire: “very satisfied”, “moderately satisfied”, “neither 
satisfied nor dissatisfied”, moderately dissatisfied, and “very dissatisfied”. 
Subjective cure rate was defined as the percentage of women answering 
“cured” on supplemental question 1, improved rate as “cured” or “better” and 
failure rate as “unchanged” or “worse” when given the choices “cured”, 
“better”, “unchanged” or “worse”. In Paper II, the criteria for failure was 
wider, and in this paper failure rate was defined as the percentage of women 
stating “not cured” (that is the sum of patients stating “better”, “unchanged” or 
“worse”. Women having undergone repeat SUI surgery (including bulking 
agents) during the 10-year follow-up was excluded when calculating the 
subjective outcomes in Paper I due to the risk of recall bias on their original 
surgery (several subjective outcomes). In Paper II, however, this risk of recall 
bias was non-existing as the sole subjective outcome was failure rate and the 
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women having had repeat SUI surgery were therefore summarily classified as 
failures when calculating failure rates in this paper.   
Secondary outcomes in Paper I were complications during or 
immediately following surgery recorded in the NFIR and any long-term 
unfavourable outcomes discovered at the 10-year follow-up.  
The complications routinely registered in the NFIR are as follows: 
• hematomas (> 4 cm) 
• superficial infections (defined as local tenderness with redness 
and/or purulent discharge) 
• deep infections (defined as abscess formation with or without 
sinus tract formation) 
• bladder perforations 
• urethral injury 
• bowel injury 
• major vessel injury 
• major bleeding (> 500 ml) 
• catheterization (> 1 week) 
• catheterization (> 1 month) 
• postoperative vaginal mesh exposure 
• postoperative sling release.  
The long-term unfavourable outcomes evaluated at 10-year follow-up 
included the following:  
• the rate of patients with low Qmax (defined as < 15 ml/s). 
• PVRs > 100 ml and > 200 ml 
• asymptomatic vaginal mesh exposures 
• subjective voiding difficulties (calculated from supplemental 
question 2, see section 3.3.1) 
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• recurrent urinary tract infections (defined as having received more 
than three antibiotic treatments over the last 6 months) 
• persistent painful voiding (calculated from supplemental question 
3, see section 3.3.1) 
• de novo urgency incontinence (defined as a woman with no 
preoperative symptoms of urgency incontinence (urgency 
incontinence index score = 0) developing postoperative urgency 
incontinence (urgency incontinence index score > 0 and presently 
in the need of incontinence pads).  
 
3.5.2 The POSUI study (Paper III) 
 The primary outcomes in Paper III were the prevalence of occult urinary 
incontinence (OI) and the incidence of postoperative stress urinary 
incontinence (POSUI). OI was defined as leakage during provocation testing 
(Test 1-4), see section 3.3.3. POSUI was defined as new onset of subjective 
symptoms, regardless of severity, with a stress incontinence index score > 0 
(validated questionnaire, see section 3.3.1). The strength of a potential 
association between these primary outcomes (OI and POSUI) was tested on the 
population level and expressed as odds ratios (ORs) (see section 3.6). The 
diagnostic accuracy of OI predicting POSUI on an individual level was tested 
by the use of sensitivity, specificity, positive predictive value (PPV), negative 
predictive value (NPV), likelihood ratio for a positive result (LR+), likelihood 
ratio for a negative result (LR-) and diagnostic odds ratio (DOR) (see section 
3.6).  
The secondary outcomes were the rate of patients needing re-
intervention for severe POSUI. Re-intervention was defined as either receiving 
pelvic floor muscle training or surgical intervention. 
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3.6 Statistical analyses and power calculations 
 
 The calculated outcome data in all papers were done as per protocol 
analysis. In this thesis categorical data are presented as percentages and 
continuous data as mean (Paper III) or median (Papers I and II) and range. 
Differences in dichotomous variables were tested using McNemar’s test for 
paired variables, and Pearson’s Chi-Squared test or Fisher’s exact test for 
unpaired variables. Two-sided Fisher’s exact test was used when the sample 
size was either below 20, or below 40 if the expected count was less than 5. 
Differences between groups were tested using the Mann-Whitney-U test for 
continuous variables. Differences tested with Pearson’s Chi-Squared or 
Fisher’s exact tests were expressed as odds ratios (ORs) with 95 % confidence 
intervals.  
A significance level of 5 % was used in all papers. Uni- and multivariate 
logistic regression analyses were used for identifying risk factors in Paper II. 
In these analyses, the strength of an association between a variable and a 
binary outcome were expressed as odds ratios (ORs) with 95 % confidence 
intervals (CI) and p-values. The significance level for entering a variable into 
the multivariate model was set to 0.20. Backwards-stepwise variable selection 
was then used until all remaining variables had p < 0.05. When testing for 
significant interactions between independent variables, none were found. 
Receiver-operating characteristics curves (ROCs) were used to find an optimal 
cut-off for dichotomizing surgical age. The “ideal” cut-off value was the 
surgical age where both sensitivity and specificity were as high as possible for 
the outcome. The final multivariate model was found to fulfil both the 
Hosmer-Lemeshow goodness-of-fit test and a test for colinearity (variance 
inflation factor < 5).  
In Paper III, the Standard for Reporting of Diagnostic Accuracy (STARD) 
initiative was adhered with the exception of using a reference test, as none 
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such exists for OI (118). Diagnostic accuracy of tests and test combinations 
was estimated using sensitivity, specificity, positive predictive values (PPVs), 
negative predictive values (NPVs), likelihood ratios for positive (LR+) and 
negative (LR-) results, and diagnostic odds ratios (DORs) with 95 % 
confidence intervals (CI). 
Statistical analyses were performed using Statistical Package for the 
Social Sciences (SPSS-PC), version 15.0 for Papers I and III, and version 19 
(IBM SPSS Statistics) for Paper II. 
Sensitivity, specificity, PPV, NPV, LR+, LR-, DORs with 95 % CIs 
were all calculated manually with the exception of the 95 % CIs for LR+ and 
LR- for which an open online calculator at Centre for Evidence-Based 
Medicine Toronto was used (119).  
 No sample-size power calculation was performed for the TENT study 
(Papers I and II). This study is based on a registry database in which the 
number of patients that potentially could be included from this database gave 
us a sample size that, according to our knowledge, far exceeds most other 
publications having investigated the same aims (10-year outcomes).    
 A sample-size power calculation was, however, performed before 
commencing on the POSUI study (Paper III). The rate of a positive 
preoperative test for occult incontinence was set at 50 % based on published 
literature up to 2007, reporting a 44-80 % prevalence of occult incontinence in 
patients with POP (83;84;93-96;99). A 20 % difference in outcome (POSUI) 
between women with occult incontinence (OI) and women with negative tests 
was considered to be of clinical significance. We wanted the study to have 80 
% test power when the expected outcome (POSUI) in the test positive (OI) and 
test negative groups were 32 % and 12 % respectively. The latter was based on 
the Norwegian study by Borstad and Rud, who reported a 22 % incidence of 
POSUI after traditional Manchester operations (104). Using a free and open-
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source calculator for epidemiologic statistics (www.openepi.com), we found 
that 136 women were needed in the study. 
   
3.7 Legislation and research ethics 
 
 In all studies constituting the basis for this PhD thesis, the declaration of 
Helsinki was respected (120). Approval was given from all department heads 
and institutional personal data officers at the participating hospitals. The TENT 
study (Papers I and II) and the POSUI study (Paper III) were both evaluated by 
The Regional Committee for Medical and Health Research Ethics in South-
Eastern Norway. The POSUI study was approved in accordance with the 
Norwegian Research Ethics Act of June 30th 2006 (renamed the Health 
Research Act in 2009). The Regional Ethics Committee considered the TENT 
study to represent a quality assurance measure for a treatment already 
established and thereby exempt from additional ethical approval beyond the 
approval from all department heads and institutional personal data officers at 
the participating hospitals. It was considered to be covered within the Health 
Personnel Act § 26 and therefore outside the mandate of the Regional Research 
Ethical Committee system in Norway. We chose to obtain written consent 
from all women participating in all studies. When giving their consent for the 
TENT study, participating women also gave their consent to the inclusion of 
previously stored data in the NFIR. As the NFIR is a national quality database 
that entails the export of data outside the hospitals in which treatment was 
given, a signed consent form is always obtained from the women at the time of 
surgery. However, this signed consent does not include the collection of data 
beyond three years after surgery. It was therefore necessary to obtain 
additional written consent from women participating in the TENT study in 
order to merge the 10-year follow-up data with previously stored data in the 
NFIR.  
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 The POSUI study and the TENT study were both non-intervention 
studies, and as such not required to be registered in any public trials registry 
before study start.  
 Our own ethical evaluation as researchers and clinicians is that both the 
TENT and the POSUI study represent justified studies that carry the potential 
of great benefit to the patient groups investigated with no potential risk to any 
participants, including no violation of sensitive data issues.  
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4. SUMMARY OF RESULTS 
 
Paper I 
Long-term follow-up of the retropubic tension-free vaginal tape procedure 
 In this prospective observational study, we investigated the surgical 
outcomes of 483 women from an original cohort of 603 women that had been 
treated with the retropubic TVT procedure at the study hospitals. These 483 
women represented 89 % of the 542 women still alive 10 years after their 
surgical procedure. Subjective and objective data were collected from 327 (of 
483) patients that attended a clinical 10-year follow-up consultation. 
Additional subjective data were collected from the remaining 156 women 
undergoing a structured telephone interview only. This surgically treated 
heterogeneous cohort had originally been operated by 21 different surgeons 
and consisted of women having received TVT as either primary or secondary 
surgical treatment for SUI or MUI. The cohort included women with urethral 
hypermobility, low urethral closure pressure as well as those having undergone 
concomitant POP surgery. 
 We found that the objective long-term (10-year) cure rate was 89.9 % 
for the whole heterogeneous cohort and that only 2.3 % of the women had 
undergone repeat SUI surgery during the 10-year follow-up period. The 
objective cure rate was identical to the 6-12 months postoperative cure rate 
(90.2 % vs 89.9 %, p = 0.86). The subjective long-term outcomes calculated 
from the questionnaire were; 76.1 % of the women were cured, 18.0 % better, 
3.4 % unchanged and 2.5 % stated a worse situation. A large majority (82.6 %) 
stated that they were “very satisfied” with their treatment. The study revealed a 
small but significant decline in the percentage of women stating that they were 
“very satisfied” with the treatment from the 6-12 months follow-up to the 10-
year follow-up (89.1 % vs 82.6 %, p = 0.006) despite no change in objective 
cure rates (as stated above). 
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 There was a total complication rate of 8.7 % recorded at or immediately 
following surgery, the most frequent being hematomas of more than 4 cm in 
diameter (2.5 %). Other complications, having occurred with a frequency of 1 
% or more, were bladder perforations (1.2 %), catheterization > 1 week (1.7 
%), catheterization > 1 month (1.0 %) and postoperative sling release (1.9 %). 
Of the unfavourable long-term outcomes that were recorded at the 10-year 
follow-up, significantly more women had maximum flow rates (Qmax) < 15 
ml/s (26.7 % vs 11.0 %, p < 0.001) and post-void residuals (PVRs) above 100 
ml (3.5 % vs 0.3 %, p = 0.006) when compared with the preoperative data. 
None had PVRs above 200. A significant change in PVRs was also noted from 
the 6-12 months follow-up to the 10-year follow-up (3.5 % vs 0.7 %, p = 
0.039). The maximum flow rates were, however, highly incomplete registered 
at the 6-12 months follow-up in the NFIR due to uroflowmetry not routinely 
being used at all hospitals. The 6-12 months follow-up data concerning the 
maximum flow rate could therefore not be compared with the 10-year follow-
up data.  
 We found an increase in de novo urgency incontinence from 4.1 % at the 
6-12 month follow-up to 14.9 % at the 10-year follow-up among women 
initially diagnosed with pure SUI (p = 0.013). Women stating that they were 
“very satisfied” 10 years after surgery were also found to have significantly 
lower median urgency incontinence index scores compared to those not stating 
“very satisfied” (0 vs 5, p < 0.001). Similar results (0 vs 4.5, p < 0.001) were 
also seen comparing women stating they were “cured” after 10-years compared 
with women stating not “cured” (i.e. “better”, “unchanged” or “worse”). 
 Subjective voiding difficulties were reported by 22.8 %, the most 
common among these (43.1 %) being a slow stream or intermittent voiding. 
The percentage of women stating that they were “very satisfied” with the 
treatment was, however, similar for the women reporting voiding difficulties 
and those reporting no such problems (83.2 % vs 82.3 %, p = 0.84). 
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Furthermore, there were no differences in maximum flow rates (Qmax < 15 
ml/s) between the groups (27.7 % vs 27.1 %, p = 0.92). 
 
Paper II 
Risk Factors for Long-Term Failure of the Retropubic Tension-Free 
Vaginal Tape Procedure 
 In this study, secondary risk analyses were performed on the 483 
patients from Paper I after merging the outcome data with additional individual 
data previously stored in the NFIR. We used uni- and multivariate logistic 
regression analysis to investigate potential preoperative and operative risk 
factors for long-term (10-year) subjective and objective failure in order to 
optimize preoperative counselling. 
 Subjective failure rate was calculated from the 483 women that had 
either attended the 10-year clinical follow-up or undergone the structured 
telephone interview. The objective long-term failure rate was obtained from 
the 327 patients that had attended the clinical 10-year follow-up and undergone 
one of the pad stress tests described under section 3.3.1. The 10-year incidence 
of failure (absolute risk) for the total cohort was 25.7 % for subjective failure 
and 10.1 % for objective failure. 
 We found that age ≥ 56 years at the time of surgery was an independent 
risk factor for both subjective (OR: 2.15, CI: 1.40-3.30) and objective (OR: 
2.81, CI: 1.30-6.09) long-term failure when compared to women < 56 years.  
 Mixed urinary incontinence (MUI) before surgery, with a severe 
component of urgency incontinence symptoms (urgency incontinence index 
score ≥ 5), proved an independent risk factor for subjective (OR: 2.33, CI: 
1.27-4.28) long-term failure. MUI was, however, not found to be a risk factor 
for objective (OR: 1.39, CI: 0.51-3.79) long-term failure. Furthermore, MUI 
patients with urgency incontinence index below 5 did not show significantly 
higher subjective failure rates than women diagnosed with pure SUI.  
 56 
 Surgical complications occurring at or immediately following surgery 
also emerged as an independent risk factor for subjective (OR: 3.02, CI: 1.53-
5.95), but not objective (OR: 2.58, CI: 0.94-7.09) long-term failure in the 
multivariate analysis.  
 Neither the degree of stress urinary incontinence symptoms before 
surgery nor the amount of leakage on pad stress testing before surgery proved 
to be risk factors for long-term failure of the TVT procedure. We were also not 
able to demonstrate any association between long-term failure and previously 
POP surgery, low preoperative MUCP or concomitant POP surgery. 
 
Paper III 
Occult incontinence as predictor for postoperative stress urinary 
incontinence following pelvic organ prolapse surgery  
 In this study we aimed at measuring the statistical association of occult 
incontinence (stress urinary incontinence on prolapse reduction) in continent 
women with POP and the risk for developing postoperative stress urinary 
incontinence (POSUI) after POP surgery. We evaluated the test performance 
of four different provocation tests for diagnosing occult incontinence alone and 
in combination and their diagnostic accuracy in predicting POSUI.  
 Initially there were 204 patients included in the study. However, 47 
women had to be excluded at the second visit (during the urodynamic 
evaluation) due to subjective or objective incontinence that they had originally 
not reported as it gave them little bother (see flowchart, Figure I in Paper III). 
As shown by the flowchart, two women were excluded due to lack of 
compliance, and 15 chose to withdraw from the study after inclusion. Of the 
140 patients that completed the study, there were three women lost to follow-
up. The final analyses were therefore done per protocol on 137 patients. 
 The prevalence of occult incontinence (OI) in this cohort, using the 
information from our four performed tests, varied from 4 % to 19 %. When 
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combining tests, the prevalence of occult incontinence (positive tests) was 
found varying from 27 % to 38 %. 
 The incidence of POSUI was 17 % for the whole surgically treated 
cohort when defined as subjective incontinence (stress urinary incontinence 
index score > 0 on the questionnaire, section 3.5.2). When stratified on basis of 
the preoperatively dominating prolapse compartment, the POSUI incidences 
were 20 % (anterior compartment), 18 % (mid-compartment) and 7 % 
(posterior compartment). 
 We found a clear statistical significant association (p < 0.05) between OI 
and POSUI for Tests 3 and 4 as well as for all test combinations (A, B and C). 
This association was, however, not demonstrated for Tests 1 and 2.  
 The odds of developing POSUI given a positive preoperative test for OI 
were then as follows; Test 3 OR: 6.5 (CI: 1.6-25.4), Test 4 OR: 7.1 (CI: 2.0-
25.7), Test combination A OR. 9.0 (CI: 2.3-35.8), Test combination B OR: 7.7 
(CI: 2.1-28.4), Test combination C OR: 6.8 (CI: 1.9-24.3).  
 When evaluating the test performance for predicting the outcome 
(POSUI) on an individual level, we tested the diagnostic accuracy of both 
positive and negative tests for OI. Thus, we calculated sensitivity, specificity, 
PPV, NPV, likelihood ratios and diagnostic ORs for all tests and test 
combinations. Sensitivity for the different single tests varied from 9 % to 50 
%, with specificity values ranging from 88 % to 97 %. For test combinations, 
sensitivity ranged from 67 % to 73 %, with specificities varying from 71 % to 
82 %. PPV ranged from 22 % to 50 % for single tests, with NPV varying from 
83 % to 89 %. For test combinations, PPV ranged from 39 % to 44 % and NPV 
from 91 % to 92 %. Likelihood ratios ranged from 1.4 to 4.9 for positive single 
tests and 2.6 to 3.7 for positive test combinations. For negative tests, likelihood 
ratios varied from 0.57 to 0.97 for single tests and from 0.38 to 0.41 for test 
combinations. The highest diagnostic OR was seen for test combination A 
(DOR: 9.0 (CI: 2.3-35.8)).  
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 Only 4.4 % (6/137) of the women developed POSUI severe enough to 
need treatment and only 1.5 % (2/137) underwent surgical treatment in the 
form of a retropubic TVT during the postoperative follow-up period. 
 The women participating in the POSUI study differed slightly in mean 
surgical age (59 vs 63 years) when compared to the total population of POP 
operated women during the study period, but did not differ in regards to stage 
of prolapse or dominating POP compartment (data not shown). 
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5. DISCUSSION 
 
5.1 Methodological considerations 
 
5.1.1 Study design and study populations 
 The TENT study was designed as a population-based prospective long-
term observational study using current 10-year follow-up data and previously 
stored registry data that had been continuously recorded in the NFIR. The 
study did not incorporate a control group of non-operated women followed 
over the same time period, and some outcome data must therefore be 
interpreted with caution. The recurrence of stress urinary incontinence, the 
recurrence or occurrence of POP and urgency incontinence may be interpreted 
both as consequences of the surgical procedure 10 years ago as well as the 
effects of a normal deterioration of the pelvic floor due to advancing age. Both 
the prevalence of urgency incontinence symptoms (21;30-33) and POP (63) 
increases with age.  
 To ensure that women participating in the TENT study (Papers I and II) 
represented the “average” woman undergoing the TVT-procedure in Norway, 
the preoperative variables of these women were compared to the remaining 
women registered in the NFIR as having undergone TVT during the same time 
period at other hospitals not participating in the study. The preoperative 
variables compared are specified in section 3.1.1. The median post-void 
residual (PVR) was significantly lower (0 vs 5 ml, p<0.001), the same was the 
median preoperative maximum urethra closure pressure (MUCP) (40 vs 45cm 
H2O, p=0.03) for the participating women as compared to non-participating 
women. The median preoperative urgency incontinence index score was 
significantly higher (4 vs 3, p<0.001) for the participating women when 
compared to non-participating women. However, although these are statistical 
differences, the clinical significance is probably negligible, as the differences 
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are small. If any clinical relevance should be assigned to these differences, it 
would be that this adds strength to the favourable outcome results for the 
participants, due to the fact that both a low MUCP (121) and mixed 
incontinence (122-124) are thought to have lower cure rates than higher 
MUCP and less urgency incontinence symptoms. 
 When including patients for the POSUI study (Paper III), we chose not 
to include patients with even the slightest hint of urinary incontinence, even 
when this was not considered relevant or in need of treatment by the patients or 
their doctors. This was to ensure that a preoperative positive test actually 
revealed occult incontinence (OI) and not only provoked a pre-existing 
manifest SUI. It could be argued that there is an essential difference between a 
positive test predicting de novo POSUI and a positive test alerting a potential 
worsening of an already existing SUI, even though the clinical relevance for 
the patients ends up being the same.    
For the POSUI study (Paper III), we also wanted to test for selection 
bias (post study analysis). We did this by comparing study-women to other 
women having had POP surgery in the same time period at our Department, 
but who for some reason did not participate in the study. The variables 
compared were surgical age, preoperative stage of POP and dominating 
prolapse compartment. A database had been created for the POSUI study in 
which participants were given a study number. The identifying code-list was 
kept separate from the database. The participants were, however, also routinely 
registered in the local quality database for prolapse-operated patients at the 
Department. Unfortunately they were given a different number in this 
database. Comparing the databases in order to look for any selection bias was 
not planned at study start. Therefore, when the decision was made to compare 
study patients (study database) to other POP operated patients (controls in the 
local quality database), it was deemed too difficult to identify and remove 
study-patients from the control group as this would mean removing them 
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manually using two different code lists. This did weaken the comparison 
between the study participants and the non-study participants, as we had to use 
the total database of operated women as a control, which means that the study 
patients then also constituted 29 % of the “controls”. We do recognise that 
comparing study patients with a control group consisting only of POP operated 
patients not participating in the study would have been scientifically desirable 
and possibly could have generated a different result. In our analysis, however, 
the only difference found between the groups (of all POP operated women and 
the ones that were included in our study) was a slight difference in surgical 
age; the study patients being in mean 4 years younger at the time of surgery 
than the control group (59 vs 63 years). However, no differences in stage of 
prolapse or dominating compartment were found. The difference in surgical 
age was interpreted as a sign of incontinence being more frequent in older 
patients thereby precluding them from study participation. 
 The POSUI study (Paper III) was not powered to perform sub-analyses 
on POSUI prediction after stratifying patients based on the dominating 
preoperative POP compartment. The details regarding the power calculation 
are elaborated in section 3.6. 
   
5.1.2 Questionnaire  
 The validated short-form urinary incontinence disease-specific 
questionnaire called NFIR questionnaire (previously named NUGG 
questionnaire) is used by all hospitals reporting to the NFIR (as detailed in 
section 3.3.1), Appendices 1 and 2 (115). It was validated as a questionnaire 
meant to be filled in by the patients without any help from health-
professionals. However, in both the TENT study and the POSUI study, the 
questionnaire was used as a template for a structured interview and thereby 
filled in by a health professional based on the patient’s response. We do not 
feel that this reduces the validity of the questionnaire as this method allowed 
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any potential misunderstandings to be corrected immediately and thereby, in 
our opinion, helping to improve the quality of the patient response.  
The NFIR questionnaire assesses the specific symptoms of urgency 
urinary incontinence and stress urinary incontinence and the severity of these 
symptoms by generating specified index scores (stress incontinence index 
score and urgency incontinence index score) as detailed under section 3.3.1. In 
addition, the questionnaire also generates a quality of life score (Qol index 
score). However, the Qol index score was not used as an outcome in the 
analyses for any of the papers constituting this thesis for reasons elaborated 
below. 
The NFIR questionnaire was the only questionnaire used in this thesis 
for the following reasons:  
1. It secured uniform comparison of the individual patient 10-year symptoms 
scores to the previously recorded individual symptom scores (based on the 
same questionnaire) in the NFIR (preoperatively and at the 6-12 months 
follow-up).  
2. It allowed for a coherent definition of subjective urinary incontinence in all 
the papers. 
 
In order to limit the number of study outcomes, we decided not to use 
the Qol index scores when comparing 10-year data to previously stored data. 
Nor did we use the Qol index to define subjective cure. We considered that the 
use of this derived and complex QoL score to define cure would be 
unsatisfactory, as a cut-off for subjective cure could vary between patients. 
Also, we regarded that the patients’ own subjective definition of whether or 
not they were cured would be a simpler and possibly more reliable subjective 
outcome variable. We therefore created a short supplemental question to the 
questionnaire, enabling the patients to characterize their current leakage 
situation as “cured”, “better”, “unchanged” or “worse”. A total of three 
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supplemental questions were added to the 10-year questionnaire and used in 
Papers I and II, as previously described in section 3.3.1. We also had 
pragmatic reasons for not adding additional Qol questions or using other 
validated Qol questionnaires such as the IIQ-7 (125), the UDI-6 (125) or the 
UISS (126), which are all Grade A questionnaires recommended by the ICI 
(24).  One important reason was the wish to keep the total questionnaire short, 
and thereby reduce the patients’ workload, possibly increasing attendance in 
our 10-year follow-up study. Furthermore, using additional Qol questionnaires 
would require that these first were validated in Norwegian. This was deemed 
unnecessary, as we viewed the NFIR questionnaire supplied by the 3 new non-
validated questions adequate for the studies comprising this thesis. 
In regards to assessing POP symptoms, no validated questionnaire (such 
as the PDFI (127) recommended as Grade A by the ICI (24)) was used, as no 
questionnaire assessing POP symptoms was validated in Norwegian at the time 
of study start. At the planning stage of the POSUI study (Paper III), we 
discussed whether a formal translation and validation of a symptom 
questionnaire should be undertaken. We deemed this not to be necessary, as 
our study aim was not to evaluate the efficacy of POP surgery on symptom 
relief, but to measure the possible association between OI and POSUI and 
evaluate test performances of different OI tests.  
 The clinical investigation methods, definitions, and units in all papers 
constituting this thesis conform to the standards recommended by the 
ICS/IUGA with two exceptions. These exceptions include a different definition 
of recurrent urinary tract infections (UTIs) and the use of the term “occult 
urinary incontinence” instead of the recommended ICS/IUGA term (which is 
stress urinary incontinence on prolapse reduction (19)). We chose not to use 
the ICS/IUGA definition of recurrent urinary tract infections (UTIs), defined 
as at least three symptomatic and medically diagnosed UTIs during the 
previous 12 months (19). Instead we defined recurrent UTI in our study as 
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having received more than three antibiotic treatments over the last 6 months, 
based on the information given by the patient in the NFIR questionnaire 
(Appendices 1 and 2, question 8). The NFIR question regarding UTIs asks the 
patient how many treatments for UTIs they have received over the last 6 
months categorizing into 5 category responses (“never”, “once”, “2-3 times”, 
“4 times” or “more than 4 times”). We defined the patients as having recurrent 
UTI if they chose one of the last two scores.  
The reason for keeping the old term “occult incontinence” over the new 
ICS/IUGA term (stress urinary incontinence on prolapse reduction) when 
describing the stress urinary leakage that a continent woman with POP may 
display during provocation testing mimicking POP repair, was that we felt the 
new ICS/IUGA term suggests or hints of this condition being an illness or 
entity by its own. Occult incontinence (OI) is, in our opinion, the description of 
a test-result (positive). OI may also be described as a risk marker that may or 
may not predict a specified unwanted outcome (such as POSUI), but not by 
itself represent something that needs treatment.  
 
5.1.3 Occult incontinence testing 
There is to date no consensus on how best to test for OI, and no 
reference test has been agreed upon. As described in section 3.6, the guidelines 
developed by the STARD initiative were attempted adhered to when 
evaluating the performance of OI as a risk marker for POSUI (118). However, 
to fully make use of these guidelines, testing against a reference test would 
have been preferable when evaluating the validity of different OI tests (118). 
Instead, we made a selection from the wide variety of tests for OI suggested in 
the literature. These tests differs greatly in mode of prolapse reduction (using 
vaginal packing, pessary, manual/digital repositioning, forceps, speculum etc), 
type of provocation (Valsalva, cough, different exercise regimen or activities 
of daily living), positioning during testing (supine, standing, sitting, lithotomy, 
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semi-lithotomy) and bladder volumes during testing (83;84;86-89;92-102). 
From the tests suggested in the literature at the time of study planning, we 
therefore chose the tests detailed in section 3.3.3.  
We decided against vaginal packing or the use of a speculum, as we 
believe these methods carries the risk of a false high number of positive tests 
(false positives). Using such a prolapse reduction method would imply 
exerting pressure on the levator ani muscles, potentially neutralizing the 
normal reflex contraction during coughing, with increased risk of cough 
related urinary incontinence. Care was taken in finding an optimally fitted 
therapeutic pessary ring that did not exert unwanted pressure on neither the 
levator ani muscles nor the urethra as an ill fitted pessary ring might obstruct 
the urethra resulting in a false negative for this sign (OI). 
No test was performed with bladder volumes larger than 300 ml as other 
studies have demonstrated that no additional information is to be gained by 
testing beyond 300 ml (88).  
The highest prevalence of OI (19 %) in our study was found when 
women wore an optimally fitted pessary ring over a time period of minimum 1 
week. The occurrence of OI is a known side effect when using pessary as a 
treatment option for POP and has been shown to occur in approximately 20 % 
of otherwise continent POP women choosing this treatment option (128). We 
believe that the higher prevalence of OI found during continuous use might be 
explained by the fact that this allows for better testing of the patient’s 
continence mechanisms in activities related to everyday living. The artificial 
office setting, in which the women are lying partly naked in the semi-
lithotomic position while coughing, may have caused anxiety leading to an 
unintentional contraction of the pelvic floor, generating too many false 
negative test results.   
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5.1.4 Strengths and limitations 
 
Papers I and II (TENT study) 
It is generally accepted that efficacy studies of surgical treatment 
modalities are best investigated in randomized controlled trials. However, as 
this means selecting women based on strict inclusion and exclusion criteria 
(often treated and followed-up by dedicated doctors), an argument can be made 
that this might not always reflect how well a treatment performs in the general 
clinical setting. In Papers I and II, we instead chose to include the whole 
surgically treated cohort using a quality database (the NFIR) to identify the 
relevant study subjects. The only exclusion criterion was the inability to give 
informed consent. Using the national registry (NFIR), we minimized the 
chances of selection bias. This allowed for the study comprising all subgroups 
of patients offered and accepting the TVT treatment in Norway. These patients 
have been surgically treated by various surgeons with different levels of 
training and clinical performance in regards to patient numbers treated. In our 
opinion, this use of the total surgically treated cohort better reflected the 
procedure’s efficacy in the “the real world” clinical setting. 
The large number of patients included in the TENT study also added 
strengths to the external validity of the results, as it is the largest published 
study in the world to date evaluating long-term outcomes in women having 
undergone the retropubic TVT procedure.  
The fact that participating Norwegian gynaecological departments 
(surgical units) were high-volume centres was considered an important factor 
conducting this type of efficacy study. Others have shown that cure rates are 
highly susceptible to variations in the number of patients operated within a unit 
per year (reflecting the volume of training each surgeon gets during a year) 
(129;130).  
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The external validity of the results in Papers I and II (the TENT study) 
might be questioned, as the study-population consisted of a Norwegian cohort 
of women living in an industrialized country with a free-of-cost public health 
system. The results might have looked different had the TENT study been 
conducted in a country where socioeconomic factors have greater impact on 
patient selection. However, we believe that the socio-economic situation in 
Norway leads to our data better reflecting the clinical needs of the whole 
population that undergo a TVT procedure. 
 Furthermore, it is important to recognize that patients registered in the 
NFIR are the ones selected for surgery for urinary incontinence, not reflecting 
the whole urinary incontinent patient population. The selection criteria used 
might therefore impact outcomes and the risk factors for failure might also 
have looked different had the whole population suffering from SUI or MUI 
been selected for surgery. We have no data that can compare the TVT to the 
non-TVT operated population, but we assume that the very young women yet 
to undergo pregnancies and the oldest women with severe co-morbidities and 
complex incontinence mechanisms may not have been offered TVT surgery as 
a treatment option.  
 Papers I and II are based on combining current data found at the 10-year 
follow-up with previously stored data in the NFIR. Using registry data carries 
the potential risk of inaccuracies in the individual entries since all information 
is manually and consecutively entered at the respective departments. A formal 
validation of variables stored in the NFIR compared to the patients’ actual 
medical records has never been performed. However, a recent study evaluating 
the validity of selected data in the National Danish Urogynaecologic Database 
(DugaBase) found the inaccuracies of recorded data to be < 10 % for all 
investigated variables when compared with the individual patient’s medical 
records (131). We can think of no conceivable reason for this to be worse for 
the data recorded in the NFIR, as the data is manually and consecutively 
 68 
entered at the respective departments in a similar manner. We also have no 
reason to assume that such minor inaccuracies would have weakened the 
conclusions in our studies, as it is unlikely that such inaccuracies would 
hamper the study groups differently in a systematic manner  
 An additional limitation of Papers I and II is the lost to follow-up (11 %) 
rate. In Paper III, only 3 women were lost to follow-up. The possible impact on 
the results from the lost to follow-up is elaborated in section 5.1.5.  
BMI at the time of surgery, as an individual risk factor for long-term 
failure, could not be included in the logistic regression analyses performed in 
Paper II, as this was not recorded in the NFIR until recently. This would have 
been an interesting variable to study, as previous studies have been conflicting. 
Several studies report good short-term outcomes for the obese women (132-
134), while Hellberg et al demonstrated poorer results after a mean follow-up 
of 5.7 years for women with BMI > 35 (135). However, we did record the BMI 
at the 10-year follow-up in our TENT study. If the lowest BMI class is ignored 
(and this class included very few patients), there seem to be a significant 
increase in subjective failure with increasing BMI. Notably, this is the BMI at 
the 10-year follow-up and not at the time of surgery. The results of these 
analyses are presented in table I below, and not published in any of the papers. 
For objective failure, no such association could be found. Using the same cut-
off for surgical age as in the logistic regression analyses (< ≥ 56 years), the 
same trend of a higher subjective failure rate in women with higher BMI was 
observed in both age categories, but this was not found for the objective failure 
rates (data not shown). Both symptoms of SUI and UUI are known to increase 
with increasing BMIs (136). The discrepancy between subjective and objective 
failure rates could possibly be the result of differences in sample size. There 
were considerable less women with available BMI information that had been 
submitted to a stress test at the 10-year follow-up compared to the number of 
women filling in the questionnaire.  
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Table I  
10-year failure rates for the whole cohort according to BMI at the 10 year 
follow-up 
   
BMI (kg/m2) 
at the 10-year  
TENT follow-up 
10-year 
incidence of 
objective 
failure 
n = 316  
(11 missing) 
 
Fisher’s 
Exact Test 
P value 
10-year 
incidence of 
subjective 
failure 
n = 481  
(2 missing) 
 
Fisher’s 
Exact Test 
P value 
< 18.5 
(underweight) 
50.0 % (n = 2)  
not included in 
the risk 
analysis 
 
 
 
 
 
0.831 
25.0 % (n = 4)  
not included in 
the risk analysis 
 
 
 
 
 
0.046 
 
 
18.5-24.9  
(normal weight) 
 
9.0 % 22.3 % 
25.0-29.9  
(overweight) 
 
11.3 % 23.8 % 
> 30  
(obese) 
9.2 % 35.4 % 
 
   
Although the 10-year TENT follow-up BMI could be regarded as a 
proxy for BMI at the time of surgery, it remains an uncertain variable. Many 
patients loose weight after having undergone incontinence surgery, allowing 
them to resume an active physical lifestyle, thereby changing BMI category 
 70 
postoperatively. In addition, many women put on weight when getting older 
(137). The BMIs at the 10-year follow-up were thus not included in the logistic 
analyses of risk factors for failure after TVT in Paper II. 
 
Paper III (POSUI study) 
To our knowledge, the POSUI study (Paper III) is one of only a few 
studies that, with an adequate sample size, have been able to demonstrate the 
statistical association between OI and POSUI. This association was also 
demonstrated in the non-intervention arm of the CARE trial (88). The POSUI 
study is also one of the first non-intervention studies published and thereby 
contributes important non-biased knowledge of POSUI incidences after POP 
surgery (89;98;104;105;138). Later there have been additional non-
intervention studies published (101;111;139). With the exception of testing 
against a reference test, we adhered to the guidelines for evaluating and 
reporting recommended by the Standard for Reporting of Diagnostic Accuracy 
(STARD) initiative (118). This implies a full evaluation of the diagnostic 
accuracy, not just the sensitivity and specificity but also PPV, NPV, LR+, LR- 
and the DORs. 
 In this paper, it might be argued that the time from surgery to the follow-
up visit might be too short in order to identify all patients developing 
bothersome POSUI warranting incontinence surgery. The mean postoperative 
follow-up was 5 months. Some women might in theory be unwilling to 
undergo new surgery so soon after their POP surgery, although we have no 
actual knowledge of this being true for any woman participating in the study. 
In the non-intervention arm of the CARE trial, the percentage of women 
meeting the stress incontinence endpoint was approximately the same at two 
years compared to the 3-months postoperative assessment (140). We therefore 
conclude that a longer follow-up time than 6 months would not likely have 
significantly impacted our conclusions. 
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 It might also be argued that the heterogeneity regarding the types of 
pelvic organ prolapses included in the POSUI study and types of prolapse 
surgeries performed may have had a significant impact on the result. However, 
the heterogeneity was deliberate, as we wanted to identify an occult 
incontinence (OI) test (or a test combination) simple enough to be 
implemented in an ordinary clinical setting comprising a heterogeneous POP 
population. OI can be demonstrated by prolapse reduction in any compartment, 
even when there is only an isolated defect in the posterior vaginal wall (141). 
Performing a subgroup analysis on the women having undergone the 
Manchester procedure (67 % of our total POSUI study population), we found 
no difference in test performance regarding the prediction of POSUI when 
compared to the total study population (data not shown).  
No synthetic vaginal meshes were used in the POP repairs of the women 
included in this study. This was due to the fact that our Department has been 
sceptical of using synthetic meshes in vaginal POP surgery. The potentially 
severe complications in some patients (such as mesh exposure) leading to the 
FDA warning of restricted use in vaginal surgical repairs, has given further 
support to our policy of preferring the native tissue repair methods for POP 
surgeries. Our Department has had a quality database in which subjective and 
objective 1-year postoperative results have been consecutively stored since 
2002. This has shown such good subjective and objective results after native 
tissue repair that a transition to mesh surgery was never deemed necessary 
(142). Synthetic meshes used in the anterior compartment have also been 
associated with a higher rate of POSUI than traditional surgery using native 
tissues, possibly due to overcorrection of the anatomy (106;107).   
 We recognise that excluding patients with minor symptoms of 
incontinence from participating in the POSUI study (see flowchart of Figure I, 
Paper III), even if this gave no bothersome symptoms, may have reduced the 
clinical relevance of the study as many POP patients have a minor degree of 
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SUI. Such a patient selection could also have contributed to the low percentage 
of clinically significant POSUI shown in our study. However, as previously 
detailed above in section 5.1.1, we believe there is a principal difference 
between a positive provocation test revealing OI in an otherwise continent 
woman and a test causing aggravation of already existing SUI symptoms (even 
minor). Only the former can in our opinion be called “true” OI. 
 No blinding of the surgeons or the doctors performing the postoperative 
evaluations in regards to the preoperative test results was done in the POSUI 
study. However, we do not believe this had any significant impact on the 
outcomes and conclusion in our study due to the fact that type of surgery was 
decided upon before testing, and our primary outcome was based on subjective 
information supplied by the patients on a validated questionnaire. The patients 
themselves were not actively informed about their preoperative testing status.  
 
5.1.5 Statistical analyses 
 
Missing values/Lost to follow-up 
 The calculated results in both the TENT study (Papers I and II) and the 
POSUI study (Paper III) were based on per protocol analysis. An alternative 
approach could have been to use Intention to treat (ITT) analysis applying the 
Last-Observation-Carried Forward (LOCF) approach when analyzing the 
outcomes in Paper I, as this was an efficacy study evaluating a treatment 
modality. However, we discarded the Last-Observation-Carried Forward 
(LOCF) method for the following reason: Our study population was originally 
not selected as participants in a clinical trial at the treatment decision time (10-
12 years ago). The data from the TVT operated women were only sent (de-
identified) to the NFIR at the time of surgery and at the 6-12 months follow-up 
as a quality assurance measure for the treatment given. When it was decided to 
use these data in the TENT study (Papers I and II) and merge them with the 
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10-year follow-up data, additional written consent had to be obtained from the 
women participating in the study. This written consent was given by the 
women at the 10-year follow-up visit, and consent to use previously stored 
data from women not participating could therefore not be obtained. This 
precluded the use of LOCF in Paper I. 
 The number of women lost to follow-up comprises a challenge to any 
study, including ours. When conducting a long-term follow-up study 10 years 
after the initial treatment the challenge is multiplied, as even some women 
satisfied with the treatment may not find time in their busy life allowing them 
to visit the clinic. Furthermore, it is conceivable that some women might be so 
disappointed with their treatment or have no confidence left in those working 
at their local hospitals, resulting in them not wanting to participate in a follow-
up study. A high lost to follow-up will inevitably impact the statistical power 
of the study. Furthermore, it may generate bias, and thereby reduce the 
confidence in the results. We tried to minimize the lost to follow-up rate by 
offering women, who declined coming to the outpatient clinic, a structured 
telephone interview for subjective data. In the TENT study (Papers I and II), 
lost to follow-up was only 11 %, after excluding women who were no longer 
alive at the time of follow-up. We made no assumption whether these lost to 
follow-up women, or deceased women, were most likely to be categorized as 
TVT cures or failures. All analyses were done as per protocol analysis, as 
detailed above. However, we do not find it likely that women declining 
participation were less satisfied with the treatment than those participating. We 
believe the opportunity for a clinical evaluation is a strong incentive for 
patients with failed surgery or for those dissatisfied with their treatment to 
participate.  
We would have appreciated a possibility to evaluate potential bias by 
comparing participating women with those declining participation on baseline 
characteristics. However, as previously detailed, the written consent for 
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accessing previously stored data in the NFIR and the medical records were first 
given at the 10-year follow-up visit, precluding this possibility. All women 
having their data stored in the NFIR had, however, originally signed a consent 
form allowing the NFIR to use de-identified data in statistical analyzes 
comparing hospitals. We were therefore able to compare stored data of 
participating women to women operated at other hospitals in the same time 
period (as described in section 3.1.1). No clinically relevant differences were 
found. The authorized personnel at the NFIR performed these comparative 
analyses, and the results are presented in Paper I. We therefore assume that the 
women who were lost to follow-up most probably would distribute themselves 
equally in all outcome groups. Notably, this assumption is not supported by 
strong data, and thus possible bias caused by selection should be taken into 
account when interpreting the results. 
 
Logistic regression model/Receiver-operating characteristics (ROC) 
 In Paper II (the TENT study), a multivariate logistic regression model 
was built to test potential risk factors (variables) against two separate 
outcomes. All the independent variables tested in the model generated in Paper 
II were also tested for possible effect modifications (interactions), but none 
were found. The model was also tested and found sound with a goodness-of-fit 
test (Hosmer-Lemeshow) when the variable for surgical age had been 
dichotomized using receiver-operating characteristics (ROC). By using ROC, 
the “ideal” cut-off value providing both the highest sensitivity and the highest 
specificity for the outcome can be identified. This is easily located on a ROC 
curve by finding the point highest on the vertical axis and the furthest to the 
left on the horizontal axis (upper left corner). The same surgical age (56 years) 
turned out as cut-off for both outcomes. Thus surgical age could then be 
dichotomized using 56 years as cut-off when both outcomes were analysed in 
the multivariate models.  
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5.2 Discussion of results 
 
Paper I  
 Paper I reports on the long-term efficacy of the tension-free vaginal tape 
(TVT) procedure. We found an objective cure rate of 89.9 % after 10 years for 
the whole heterogeneous patient cohort. When we compared the objective cure 
rate to the 6-12 months follow-up data there was no statistical difference (p = 
0.86). Others have also reported objective cure rates ranging from 84 % to  
93.1 %, but their long-term follow-up studies have been on smaller and more 
selective study populations (143-146). There is, to our knowledge, only one 
other study that has shown equally sustainable objective results over a 10-year 
period (145). This study from Serati et al also found sustainable subjective 
results over the same 10-year period (145). In our study, however, there was a 
small but significant decline in women stating “very satisfied” with their 
treatment from the 6-12 months follow-up visit to the 10-year follow-up visit 
(p = 0.006). The subjective cure rate demonstrated in our study (76.1 %) is also 
within the 65 % - 89.7 % range found by others (143-147). We argue that both 
the difference in objective and subjective cure rates (89.9 % vs 76.1 %) and the 
decline in women stating “very satisfied” over the 10-year follow-up period 
can be explained by the development of de novo urgency incontinence 
symptoms. This assumption is based on the fact that we were able to 
demonstrate a much lower median urgency incontinence index score in the 
group of women stating either “cured” or “very satisfied” when compared with 
the others (0 vs 4.5, p<0.001 and 0 vs 5, p<0.001 respectively). When 
specifically evaluating the rate of women stating “very satisfied” with their 
surgical treatment 10-year post surgery, we have concluded that 82.6 % “very 
satisfied” women is a satisfactory result given our heterogeneous patient 
population. This result is also well above the 74 % satisfaction rate 
demonstrated in a comparable study population from Sweden (144). More 
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women in our study considered themselves satisfied with the treatment than 
cured. This fact that some women are satisfied even if not completely cured 
resonates well with a publication from Oh et al, which reported that the 
frequency of incontinence episodes and the volume of leakage are the most 
dominating symptoms related to self-perceived disease (148). Therefore if 
these symptoms improve, the subjective satisfaction rate will likely improve, 
even if other symptoms are still present. Even though we did not specifically 
investigate whether these same variables were closest linked to patient 
satisfaction in our study, we believe this to be the most probable explanation 
for the difference between subjective cure rate (76.1 %) and satisfaction rate 
(82.6 %) found in our study.   
The subjective cure rate of 76.1 % demonstrated in our long-term 
follow-up TENT study is also far better than the 44 % demonstrated 14 years 
after Burch colposuspension, which used to be the previous gold standard in 
SUI surgery (47).  
The SUI re-operation rate (2.3 %) found in Paper I is in accordance with 
the 1.7 % - 5.6 % demonstrated in most long-term follow-up studies 
(146;147;149). In a study from Jonsson Funk et al, a cumulative incidence of 
13 % for new SUI surgery was found (150). However, these authors did not 
study retropubic TVT in particular, but compiled all types of slings and 
calculated cumulative incidences. It is therefore difficult to make a direct 
comparison between their re-operation rates and the re-operation rates found in 
our study.   
 Our study revealed a 4.2 % incidence of subsequent POP surgery 
(during the 10-year follow-up) seemingly contrasting other studies, in which 
very low rates of POP after TVT has been found (151;152). It has, in the past, 
been thought to be an association between the development of POP and having 
undergone an incontinence procedure at the bladder neck (such as the Burch 
procedure) (153;154). This association has, however, not been demonstrated 
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after TVT (151;152). Even though we did find a higher incidence of POP after 
TVT than what has been demonstrated by these other studies, our study was 
not designed to systematically evaluate persistence or de novo POP 
development after TVT, beyond recording any subsequent POP surgery. The 
incidence of 4.2 % should therefore not be interpreted as the true post-TVT 
incidence of POP. 
 We identified a post void residual (PVR) above 100 ml in 3.5 % of the 
women at the 10-year follow-up visit, which was a significant increase both 
from the 0.3 % identified before surgery and the 0.7 % found at the 6-12 
months follow-up visit. However, an overestimation of PVR might have 
occurred as the PVRs were only measured once, and repeat measurements 
have been shown to identify lower volumes (155). 
 As detailed in section 5.1.1, we found it difficult to ascribe what impact 
the surgery done 10-years earlier posed, and what impact the normal 
deterioration of the pelvic floor due to ageing had on the recurrence of SUI or 
the occurrence of POP and urgency incontinence 10 years after TVT surgery. 
However, comparing the preoperative data of PVRs with the 6-12 months and 
10-year follow-up data, we found that the greatest increase in number of 
women with PVRs > 100 ml occurred in the time period between the 6-12 
months follow-up and the 10-year follow-up. This probably indicates that the 
ageing component is the most important determinant for long-term voiding 
dysfunction, not the incontinence surgery per se. The same was noted for de 
novo urgency incontinence rates at 6-12 months and 10-year follow-up when 
only looking at women with no preoperative urgency incontinence symptoms, 
again indicating increasing age as the most probable determinant.  
A clinical worrisome high rate (22.8 %) of women stating subjective 
voiding difficulties was found at the 10-year follow-up. This was calculated 
from a supplemental question added to the 10-year questionnaire and could 
therefore not be compared with previous data. Nevertheless, it may be 
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speculated that this also represents a normal ageing effect on the lower urinary 
tract. Of the 22.8 % that stated subjective voiding difficulties, the majority 
complained of a slow or intermittent urinary stream. We were not able to 
correlate this to any objective measures of voiding dysfunction such as high 
PVRs or low Qmax. In fact we found no differences in low Qmax (defined as 
Qmax < 15 ml/s) between women stating voiding difficulties and the others 
(27.7 % vs 27.1 %, p=0.92). Nor did we find any significant differences in the 
percentage of women stating that they were “very satisfied” with their 
treatment when women stating voiding difficulties were compared to women 
stating no such difficulties (83.2% vs 82.3%, p=0.84). This has led us to the 
conclusion that the reported voiding difficulties do not represent a serious 
clinical problem for these women at the present time. However, since no 
voiding cystometry was performed, we cannot exclude a partial obstruction 
developing over time with compensatory increased detrusor pressures 
coexisting with normal urinary flows and an absence of high PVRs. Nor can 
we, without a control group of none-operated age-matched women, rule out the 
possibility that having a synthetic sling implanted speeds up or worsens the 
tissue deteriorating effects associated with an ageing pelvic floor. Further 
ageing could therefore theoretically cause these patients to experience 
increasing voiding difficulties in the future. 
 The NFIR questionnaire lack information on urgency symptoms without 
incontinence (named overactive bladder dry: OAB dry), as it was created as an 
incontinence-specific questionnaire. When used post surgery it can, however, 
provide information on urgency incontinence symptoms (named overactive 
bladder wet: OAB wet). As we wanted to calculate the long-term de novo 
urgency incontinence rates, we looked at the sub-cohort of women with pure 
SUI symptoms without any preoperative symptoms of urgency incontinence 
(preoperative urgency incontinence index score = 0) operated with the TVT 
procedure (21 %). When any new urgency incontinence symptoms resulting in 
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an urgency incontinence index score > 0 (at the 10-year follow-up) was used as 
a definition of de novo urgency incontinence, a de novo urgency incontinence 
rate of 41.6 % was found (data not published). However, many of the women 
stating some urgency incontinence symptoms did not report any need for pad 
use (one of the Qol questions in the NFIR questionnaire). We therefore 
decided to redefine de novo urgency incontinence with inclusion of the need 
for pad use. The definition decided upon therefore read: The development of 
postoperative urgency incontinence symptoms (urgency incontinence index 
score > 0) combined with the need for pad use among women with no 
preoperative symptoms of urgency incontinence (preoperative urgency 
incontinence index score = 0). Thus the rate of de novo urgency incontinence 
was, by this definition used in our study, found to be 14.9 % and in accordance 
with the 1-17 % reported by others (147;152;156).  
 
Paper II 
 Paper II reports on preoperative and operative risk factors for long-term 
failure. Although the TENT study showed high cure rates for the whole non-
selected heterogeneous cohort, there were differences in failure rates (absolute 
risks) when participating women were subdivided by their individual 
preoperative and operative characteristics.  
We believe it to be essential for women contemplating surgery to receive 
as comprehensive information as possible regarding the likelihood of long-
term success, as this may vary from woman to woman based on their 
individual characteristics. In this paper, we therefore created a multivariate 
logistic regression model in which we tested different potential preoperative 
and operative risk factors for long-term failure. The same model was used to 
test the potential risk factors against both long-term subjective and long-term 
objective failure (for definitions see section 3.5.1). 
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 A high surgical age emerged as a risk factor for both outcomes. We are 
unaware of any other study having demonstrated this association between high 
surgical age and a poor long-term (10-year) objective outcome. There is, 
however, one publication reporting an association between increasing age (by 
decade) and objective failure at 2 months follow-up (157). Regarding the 
association between high age and long-term subjective failure, this was 
previously reported by Hellberg et al (135). In their study, a poorer outcome 
was found among those over the age of 75 (at the time of follow-up) after a 
mean follow-up time of 5.7 years. However, in contrast to them only finding 
an increased failure rate among the very old, we demonstrated a clear 
difference in outcome at a much younger age (56 years at the time of surgery) 
using receiver-operating characteristics (ROC). The rationale for using ROC is 
fully explained under section 5.1.5. The cut-off at a surgical age of 56 years is 
close to the 51 years found to be the median age of spontaneous menopause 
(158). We have therefore speculated that our finding might be related to a 
weaker support of the pelvic floor at the time of surgery in the oldest age 
group. A weaker pelvic floor support might be caused by the age-induced loss 
of muscle strength and/or the impairment of the elastic quality of connective 
tissue that are known to accelerate after menopause (159;160). 
 Experiencing surgical complications at or immediately following 
surgery was also found to be a risk factor for long-term subjective failure. This 
has to our knowledge also not been demonstrated previously. The low numbers 
of complications prevented analysis regarding specific types of complications 
and the complications were therefore in the model dichotomized into yes or no. 
A conceivable explanation regarding how surgical complications can be a risk 
factor for failure would be that this in some way is linked to the development 
of urgency and urgency incontinence. We know that the urethra is an organ 
possessing complex neuromuscular reflex pathways that modulate bladder 
function (161). It is possible that any excess damage to these delicate 
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structures could lead to excess collagen deposition and scarring that in turn 
would lead to urgency or urgency incontinence. Such excess damage could be 
caused by repeated needle placement after bladder perforation, haematomas, 
infections or re-intervention for sling release. There is strong indication, in the 
literature, that urgency is an independent risk factor for reduced patient 
satisfaction after TVT surgery (162;163). In support of this concept, we 
demonstrated in Paper I that the median urgency incontinence index 10 years 
after surgery was higher among women not claiming to be cured or not stating 
“very satisfied” with the treatment given when compared to the others 
(detailed above under Paper I).  
The fact that complications are associated with increased long-term 
failure rates also underscores the importance of this type of surgery being 
performed by (or under guidance of) skilled surgeons only. This is also 
emphasized by others demonstrating an inversely association between failure 
rates and the number of TVT procedures performed by each surgeon 
(129;130). 
 Our study confirms that women with preoperative diagnosed MUI 
treated with retropubic TVT have a poorer long-term subjective outcome than 
women with pure SUI, a finding that has also been reported by others (122-
124). However, we were also able to demonstrate that the urgency 
incontinence symptoms (measured by the stored preoperative urgency 
incontinence index score) need to be of a certain magnitude for it to have an 
impact on the outcome. MUI patients with only a small or moderate 
component of urgency incontinence symptoms (urgency incontinence index < 
5) did not significantly differ from pure SUI patients in regards to failure rates. 
The significance of the urgency incontinence component in MUI women on 
surgical results after TVT has also been verified in a study from Kulseng-
Hanssen et al from 2008 (52). 
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 Interestingly, neither the degree of preoperative stress incontinence 
symptoms, as expressed by preoperative stress incontinence index scores, or 
the amount of preoperative stress leakage on pad stress testing was found to be 
risk factors for long-term failure. This fact is also reported by others (162;163). 
However, in a prospective cohort study from Cammu et al, the use of more 
than 2 diapers a day was associated with failure after TVT in a multivariate 
logistic regression analysis (157). However, in their study the diapers were 
worn throughout the day and would therefore, in our opinion, likely comprise 
both stress and urgency incontinence episodes making it significantly different 
form the cough/jump pad stress test used in our study. This is also supported 
by the fact that they did not demonstrate the same association with failure rates 
when performing a cough stress test in the sitting position with 300 ml bladder 
volume.  
Furthermore, we were not able to detect any negative impact on the 
outcome from previous SUI surgery, concomitant POP surgery or low 
preoperative MUCPs in our study. The literature is here more conflicted. 
Rardin et al (164) found no difference in cure rates among women undergoing 
primary or repeat SUI surgery contrasting later publications from others 
demonstrating increased odds for failure when repeat midurethral sling 
procedures are performed (157;165). Low preoperative MUCPs (< 20 cm 
H2O) not being a risk factor for failure after retropubic TVT has also been 
demonstrated by others (54;124;130). However, in a study from Clemons et al, 
a MUCP ≤ 15 cm H2O was associated with short-term TVT failure (121). 
Concomitant POP surgery did not seem to increase the risk of failure for 
patients with both manifest SUI/MUI and POP. There is conflicting evidence 
in the literature as similar results have been found by some authors 
(157;162;163) while others such as Pang et al have demonstrated concomitant 
POP surgery being associated with inferior results (166). These differences 
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might be explained by population differences resulting from which patients are 
selected for concomitant procedures. 
 
Paper III 
 This paper verifies the existence of an increased risk for postoperative 
stress urinary incontinence (POSUI) after POP surgery in preoperatively 
continent POP patients demonstrating occult incontinence (OI). This 
association was found for provocation Tests 3, 4 and all test combinations, but 
not for Tests 1 and 2, probably due to a sample size problem (lowest 
prevalence of OI in Tests 1 and 2). The tests are detailed in 3.3.3. The POSUI 
study (Paper III) is one of a very few non-intervention studies with sufficient 
sample size to demonstrate the existence of this often assumed association, 
another being the Colpopexy and Urinary Reduction Efforts (CARE) trial (88). 
However, the existence of an association between OI and POSUI on a 
population level cannot alone be used as an argument for recommending 
prophylactic anti-incontinence surgery at the time of POP surgery on an 
individual level. The main additional consideration is that adding an anti-
incontinence procedure may carry a potential risk to the patient including 
longer operating time, voiding dysfunction due to bladder outlet obstruction, 
de novo OAB symptoms, vaginal mucosa extrusions and increased costs. The 
risk of intervention following bladder outlet obstruction was in a publication 
from Ballert et al found to be 9.7 % (108). In order to properly decide whether 
a woman with OI should be offered a prophylactic anti-incontinence 
procedure, it is therefore essential to know the validity of the tests by which OI 
has been diagnosed. The validity describes the tests performance in predicting 
the outcome by means of sensitivity, specificity, PPV, NPV, the likelihood 
ratios for positive (LR+) and negative (LR-) test results and diagnostic odds 
ratios (DORs).  
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We chose to follow the Standard for Reporting of Diagnostic Accuracy 
(STARD) initiative from 2003 when evaluating and reporting the test results 
for OI, with the exception of using a reference test (118). The reason is that 
there is to date no consensus on a reference test for OI. Despite having 
demonstrated a clear statistical significant association between OI and POSUI, 
all our proposed tests and test combinations showed equally poor performance 
predicting on the individual level. This illustrates that ORs may not be the 
appropriate tool for describing the ability of a risk marker (such as OI) to 
identify patients likely to end up with a disadvantageous outcome (such as 
POSUI). ORs and relative risks (RRs) are epidemiological instruments 
frequently used to assess associations, but are argued by some to be poor 
instruments when using risk markers to predict outcome for individuals (167).
 The incidence of POSUI in our study was 17 % when defined as 
subjective incontinence (validated questionnaire). This result is in the lower 
end of the 11 % - 44 % range demonstrated by others (89;101;104;105;138). 
Stratified by dominating preoperative compartment (anterior-, mid- and 
posterior), the POSUI incidences were 20 %, 18 % and 7 % respectively. The 
low incidence might have been affected by the rigid exclusion of anyone with 
a hint of pre-existing urinary incontinence, as detailed in section 5.1.4. It could 
also be ascribed to the fact that the prolapse repair itself might function as an 
anti-incontinence procedure. Borstad et al performed a randomized trial, 
published in 2010, in which women with POP and SUI where randomized to 
either TVT at the time of POP repair or three months later (168). They found a 
29 % cure rate of SUI and no need for subsequent TVT in the group of women 
having had prolapse repair alone, even without any specific dissection under 
urethra or Kelly placations during the POP surgery (168).  
A few patients in our study were found to have objective evidence of 
leakage in the postoperative evaluation without having any symptoms. The 
clinical significance of this finding in asymptomatic patients is yet to be 
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established. It is possible that these women have an increased risk of 
developing SUI later in life. 
The prevalence of OI found with the tests evaluated in the POSUI study 
was lower (4 %-19 %) than previously demonstrated by others (83;84;93-
96;99). We contribute this to several reasons. One obvious reason being that 
different methods of testing are often used due to the lack of standardization, 
as detailed in section 5.1.3. In addition there may be clinical differences 
between the cohorts tested, as some studies have included patients who have 
responded “rarely” when asked about stress urinary incontinence on a 
validated questionnaire. We would argue that these women (answering 
“rarely” rather than “never”) already have a small (although insignificant) 
manifest SUI and are likely to more often have a positive provocation test than 
those denying any degree of SUI on all questions.  
The POSUI study revealed further that POP patients not demonstrating 
OI are still at risk of de novo POSUI. We found a 9 % incidence of POSUI 
among women negative on all four preoperative tests for OI. Again the 
literature is conflicting. Some recent studies have published similar results to 
ours (88;89;101;108), while several older studies report only a slight risk of 
POSUI or none at all in patients without OI (96;97;113;169). Furthermore, 
there are large studies reporting that POSUI may also occur after performing 
concomitant prophylactic anti-incontinence procedures (101;105). 
Only six patients (4.4 %) in our observational study developed 
symptomatic POSUI severe enough to warrant treatment. Only two of those 
patients (1.5 %) needed an anti-incontinence procedure (TVT) some time after 
their POP surgery. The remaining four women were treated with pelvic floor 
muscle training. This is even lower than the 7.7 % - 8.3 % of POP operated 
continent women needing subsequent SUI surgery for POSUI demonstrated by 
others (108;170). Looking specifically at the subgroup of occult incontinent 
women having POP surgery without anti-incontinence procedures, Ennemoser 
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et al recently published 2-8 years follow-up data (111). In this population only 
5.3 % of the women had received a subsequent TVT procedure for POSUI. A 
higher percentage (15.8 %) was found by Jundt et al (170). Furthermore, the 
number needed to treat with prophylactic TVT in order to prevent one 
preoperatively continent woman from having a subsequent TVT after POP 
surgery has been estimated in two randomized controlled trial to lie between 6 
and 11 (101;139). 
The low percentage of POSUI found in our study, combined with the 
estimate of up to 11 women having to receive an “unnecessary” procedure with 
potential life-long implications on voiding function to prevent one subsequent 
incontinence procedure found by others, has led us to the conclusion that the 
current “two-step” approach within our Department seem the most viable 
approach for the future. 
A further argument for the “two-step” approach is the long life 
expectancy of women and the unknown effect of a TVT after several decades. 
Many women in Norway may now expect to live until 100 years of age, and 
many of these might be in need of an incontinence procedure decades after a 
POP operation. To day, no studies have looked at the life-long effects of 
performing unnecessary TVT at younger age, concomitant with the POP repair 
(the “one-step” approach) and whether this reduces the beneficial effect of a 
new incontinence procedure performed at older age. 
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6. CONCLUSIONS  
 
This thesis demonstrates that the retropubic tension-free vaginal tape 
(TVT) procedure has a very satisfactory long-term subjective and objective 
outcome with a low re-operation rate. The procedure has good efficacy, even 
when used on an unselected heterogeneous cohort of women with numerous 
surgeons in a high-volume clinical setting across different hospitals. 
Our TENT study showed a small decline in treatment satisfaction seen 
over the 10-year follow-up period despite no change in objectively measured 
results. We believe this is explained by the increase in urgency incontinence 
symptoms seen during the follow-up period. The relationship between 
increased urgency incontinence symptoms and reduced patient satisfaction is 
demonstrated by the fact that women not stating “very satisfied” with the 
treatment had significantly more urgency incontinence symptoms at the 10-
year follow-up visit (higher urgency incontinence index scores) compared to 
the women reporting to be “very satisfied” with the treatment.   
 The TVT procedure had few serious surgical complications registered at 
or immediately following surgery, but the total surgical complication rate was 
almost one in ten (8.7 %). Experiencing a surgical complication also seems to 
be an individual risk factor for long-term failure and underscores the 
importance of this surgery being performed by (or under the guidance of) 
experienced surgeons. Among the long-term unfavourable outcomes 
registered, de novo urgency incontinence and subjective voiding difficulties 
were the most prominent reported by the women. The most frequently stated 
voiding difficulty was the feeling of a slow or intermittent urinary stream. 
However, no significant difference in percentage of women declaring 
themselves “very satisfied” with the operation was found comparing women 
stating voiding difficulties to women stating no such difficulties. Furthermore, 
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few women were found to have objectively measurable voiding difficulties at 
the 10-year follow-up (low Qmax and/or high PVRs). 
Whether the reported de novo urgency incontinence or the subjective 
voiding difficulties are related to the procedure given 10 years ago, or are 
related to normal deterioration of the pelvic floor caused by advancing age, 
cannot fully be answered by this thesis. 
 We found the long-term (10-year) failure rate after retropubic TVT to be 
low for the whole cohort studied. However, a surgical age ≥ 56 years, high 
degree of preoperative urgency incontinence symptoms and surgical 
complications all seem to exert a negative impact on the long-term outcome. 
The negative effect of mixed urinary incontinence (MUI) was only seen when 
the amount of urgency incontinence symptoms was severe. Thus having MUI 
is not by itself a risk factor for failure. MUI women, in whom the component 
of urgency incontinence symptoms was below 5 on the urgency incontinence 
index, did not display any increased risk of long-term failure when compared 
to women having a pure SUI. Neither the degree of stress incontinence 
symptoms, amount of stress urinary leakage, previous SUI surgery, low 
preoperative MUCP or concomitant POP surgery were found to assert any 
negative impact on the long-term outcome. 
This thesis demonstrates further (with the POSUI study) that very few 
preoperatively continent women develop POSUI severe enough to warrant 
later incontinence surgery after POP surgery. There is a positive statistical 
association between occult incontinence (OI) and the risk of developing 
POSUI after POP surgery on a population level. However, even though this 
association is seemingly strong (high ORs), OI is a poor risk marker for 
identifying individual women in need of prophylactic anti-incontinence 
surgery at the time of POP surgery.  
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7. RECOMMENDATIONS AND CLINICAL PERSPECTIVES  
 
 The findings in this thesis should be presented to women contemplating 
incontinence surgery or pelvic organ prolapse repair. The fact that retropubic 
TVT has far better long-term results than any previously used surgical method 
for SUI and MUI makes TVT the method of choice offered to women when 
surgical treatment for these conditions is considered. At present, we do not 
know whether the new modified mid-urethral slings can demonstrate similarly 
excellent long-term results. As this type of surgery is not for a life threatening 
disease, the women should be informed that the operation is irreversible and 
that their voiding function might be affected. They should be made aware that, 
even though few women develop objectively measurable voiding impairment, 
almost one in four state subjective voiding difficulties and 15 % develop new 
urgency incontinence symptoms during the first 10 years after surgery. Both 
conditions are difficult to treat and might impair quality of life. However, the 
information should be balanced, as one cannot with absolutely certainty 
contribute these lower urinary tract symptoms to the procedure itself, as it 
might just as well be related to a normal age related deterioration of the pelvic 
floor.  
By taking the women’s individual preoperative characteristics into 
account, a more accurate and realistic information regarding long-term results 
from retropubic TVT surgery can be given prior to the operation. Women with 
individual risk factors for failure might in this way be forewarned that a good 
short-term result might not be lasting a lifetime and that there might be a need 
for additional treatment later in life.  
The findings of this thesis will help empowering both women and 
physicians to better decide whether or not to opt for surgery as a treatment 
option for a condition that is not life threatening but severely reduces the 
quality of life for a great number of women.  
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 Concomitant POP surgery does not seem to negatively impact the long-
term outcomes of TVT surgery in women with concomitant urinary 
incontinence and POP, in favour of a “one-step” approach. However, there is a 
great difference in offering a “one-step” approach to women suffering from 
both incontinence and POP and offering it as a prophylactic procedure to POP 
women with no symptoms of SUI or MUI. When investigating preoperatively 
continent women undergoing POP surgery, we found a very low number of 
patients in need of additional incontinence surgery after POP surgery. 
Therefore, offering TVT as a prophylactic anti-incontinence procedure to 
every continent woman undergoing POP surgery hardly seems ethical and not 
clinically justified. Even though we were able to demonstrate an association 
between OI and a risk for POSUI on a population level, the predictive value of 
OI as a marker for identifying individual women at risk for POSUI was so poor 
that it cannot be considered ethically justified to offer TVT as a prophylactic 
procedure even to these women.  
As a consequence, there seems to be no benefit in occult incontinence 
testing prior to POP operations. This time-consuming preoperative evaluation 
should therefore be omitted from the preoperative evaluation of continent 
women planning POP surgery, as it has no demonstrable benefit or clinical 
relevance. Furthermore, continent women demonstrating leakage on barrier 
tests (such as a pessary) should not be told that they have an increased risk of 
developing POSUI, they should rather be reassured that the risk is low, and 
that there is additional help in the form of a procedure with excellent long-term 
results to be given should they be among the few developing POSUI (in a 
“two-step” setting).  
The recommendation of this thesis is to reserve incontinence surgery in 
POP patients for the few patients who develop bothersome POSUI after the 
POP surgery (using a “two-step” surgical approach). 
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8. ERRATA 
 
Paper II: Table I: the upper tertile for the preoperative stress tests in the first 
column of the table should read > 66.7 percentile, not > 66.1 percentile. 
 
Paper III: Last page, first paragraph in the discussion section should read: Our 
selected group did, however, differ slightly in age, being on average 4 years 
younger than the total group. Not 3 years as it currently reads in Paper III (59 
vs 63 years). 
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11. APPENDICES 
Appendix 1 
The Norwegian Female Incontinence Registry (NFIR) urinary 
incontinence questionnaire (English version). 
Sigurd Kulseng-Hanssen has translated the NFIR urinary incontinence 
questionnaire below to English version. It has not been retranslated to 
Norwegian.  
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Produced by the Norwegian UroGynaecological Group 
 
Norwegian UroGynaecological Group, (NUGG) urinary incontinence questionnaire . 
 
Hospital id.   Patent id.  Date  Age 
 
Please answer all the questions.  Mark by use of dark blue or black marker pen or ballpoint pen.  Don’t fold 
the paper.   
(Mark yes, no or not relevant for each alternative in question 1.) yes no not relevant 
1. Do you leak urine?   
when you cough         
when you sneeze 
when you laugh 
when you walk up or down in stairs 
when you raise from bed 
when you lift heavy objects  
during physical activity (running to the catch the bus) 
during sports 
during intercourse 
 
(Mark one alternative for each question from 2 to 6) 
2. How often do you leak urine in relation to physical activity, when you laugh, cough or sneeze? 
never 
 1 – 4 times each month 
 1 – 6 times each week 
once per day  
more than once per day 
 
3. How large is the amount of urine you usually leak during physical activity or when you laugh, cough or 
sneeze?   
nothing 
drops / moist underwear 
dripping / wet underwear  
running / passes through all you clothes,  
running down  your legs or down at the floor 
 
4. How often do you experience sudden and imperious need to void and urinary leakage before you reach 
the toilet? 
never  
1 – 4 times per month 
1 – 6 times per week 
once per day 
more than once per day 
 
5. How large is the amount of urine you usually leak when you experience sudden and imperious need to 
void and urinary leakage 
nothing 
drops / moist underwear 
dripping / wet underwear  
running / passes through all you clothes,  
running down  your legs or down at the floor 
 
6. If you experience symptoms both as those described in question 2 and question 4, 
what is troubling you the most? 
 leakage during physical activities more than leakage related to urge 
leakage during urge more than leakage during physical activity 
equally trouble by leakage during urge as by leakage during physical activity. 
I don’t have leakage as described in question 2 nor in question 4. 
 
(Mark only one alternative for each question 7 – 11) 
7. How many incontinence pads du you use? 
none      1 – 3 per week    4 – 6 per week      1 – 4 per day   more than 4 per day 
 
Produced by the Norwegian UroGynaecological Group 
 
8. How many times have you been treated for cystitis the last 6 months   
never    once                         2 – 3 times            4 times  more than 4 times 
 
9. How often do you avoid activities (for example a hobby, physical training or going out) because you are 
afraid of leaking urine? 
never    seldom  sometimes       often             always 
 
10. Do you avoid places and situations where you are aware of that a toilet is not easily available? 
never    seldom  sometimes       often             always 
 
11. Is your sexual life influenced by your leakage problem? (To be answered before treatment.) 
not relevant  
substantially      some                   unchanged       some    substantial 
 improved     improvement                     deterioration   deterioration  
 
Mark yes, no or not relevant for each question under 12 
12. Does your urinary leakage influence            yes          no not relevant  
 
your vacation?         
your family life? 
your social life (going out, meeting friends)? 
 your sleep? 
 
(Mark only one alternative for each question 13 – 14) 
13. Is your sexual life influenced by your leakage problem?  (To be answered after treatment.) 
not relevant  
substantially      some                   unchanged       some    substantial 
 improved     improvement                     deterioration   deterioration  
 
14. Are you satisfied with the result of the treatment you have received in order to cure your urinary 
leakage? 
Very   moderately     neither satisfied      moderately   very                       
 satisfied  satisfied        nor unsatisfied         unsatisfied   unsatisfied   
 
Information given in this questionnaire, will be reported to “The Register for Incontinence”, a national data base for assurance of quality.  Your name and 
identification number is not transferred.  Your identity is known exclusively by your treating physician. © S. Kulseng-Hanssen 
 
Please do not fill in.  Will be filled in by a physician. 
 
                                             Date of incontinence                          Mean. voiding volume ml. 
                                             surgery 
  
               Number of months after the operation             Leakage during 24 hours pad test gr. 
 
 
               Number of voidings per 24 hours                                 Leakage during stress test gr 
               
         Surgeon id. number          Number of earlier surgical                        Residual urine ml. 
                                                   procedures to cure incontinence 
 
Surgical procedure            open Burch             lapsc. Burch             MMK             TVT             Stamey 
 
                                           Kelly       sling      other   IVS     periurethral injection       obturator 
 
The incontinence surgical procedure was combined with a surgical procedure to cure vaginal prolaps  yes 
                  
 Date for cutting of sling                                                                                                           
 
Complications        none       bladder perforation         haematoma            superfical wound infection     
 
         deep wound infection        catether > week          katether > 1 month         other complications 
      
   
   
     
 
    
 
 
   
  
 
 
   
    
    
 
  
 
Appendix 2 
 
 
The Norwegian Female Incontinence Registry (NFIR) urinary 
incontinence questionnaire (Norwegian version). 
 
 
Dato for innfylling av skjemaet
. .
Norsk kvinnelig inkontinensregister. Spørreskjema for urinlekkasje
Vær vennlig besvar alle spørsmål.   De opplysninger som avgis på dette spørreskjema, vil bli rapportert til Norsk
kvinnelig inkontinensregister. Navn og personnummer overføres ikke. Kun din behandlende lege kjenner din identitet
1. Lekker du urin?
når du hoster
når du løfter tungt (tunge bæreposer) Ja Nei Ikke aktuelt
Ja Nei
når du nyser
når du ler
når du går i trapper
når du står opp av sengen
ved fysisk aktivitet (løper for å nå bussen)
ved sportsaktiviteter
ved samleie
Ja Nei
Ja Nei
Ja Nei
Ja Nei
Ja Nei Ikke aktuelt
Ja Nei Ikke aktuelt
Ja Nei Ikke aktuelt
2.
(Kryss av et alternativ  for hvert av spørsmålene 2 - 6)
Hvor ofte lekker du urin i forbindelse med fysisk aktivitet, når du ler, hoster eller nyser?
aldri
1-4 ganger per måned
1-6 ganger per uke
1 gang per dag
mer enn 1 gang per dag
3. Hvor stor mengde urin lekker du vanligvis ved fysisk aktivitet, når du ler, hoster eller nyser?
ingen
dråper/fuktig undertøy
drypper/vått undertøy
renner/går gjennom ytterklær
renner nedover bena eller ned på gulvet
4. Hvor ofte opplever du plutselig sterk trang til å late vannet og lekker urin før du når frem til toalettet?
aldri
1-4 ganger per måned
1-6 ganger per uke
1 gang per dag
mer enn 1 gang per dag
5. Hvor stor mengde urin lekker du vanligvis når du har trang til å late vannet og lekker urin før du når frem til toalettet?
ingen
dråper/fuktig undertøy
drypper/vått undertøy
renner/går gjennom ytterklær
renner nedover bena eller ned på gulvet
6. Dersom du har symptomer både som i spørsmål 2 og spørsmål 4, hva er du mest plaget av?
lekkasje ved fysisk aktivitet mer enn lekkasje ved trang
lekkasje ved trang mer enn ved lekkasje ved fysisk aktivitet
like mye plaget av lekkasje ved trang som ved lekkasje ved fysisk aktivitet
har ikke lekkasje hverken som under spørsmål 2 eller spørsmål 4
(Kryss av ja, nei, eller ikke aktuelt for alle alternativer i spørsmål 1)
1.11.05.10
Pre og peroperativ registrering
pasientnummer
Draft
7. Hvor mange inkontinensbind bruker du?
(Kryss av ett alternativ for hvert av spørsmålene 7 - 11)
ingen 1-3 per uke 4-6 per uke 1-4 per dag mer enn 4 per dag
8. Hvor mange ganger har du fått behandling for blærekatarr de siste 6 månedene?
aldri 1 gang 2 - 3 ganger 4 ganger mer enn 4 ganger
9. Hvor ofte unnlater du aktiviteter (f.eks en hobby, fysisk trening eller gå ut) fordi du er
redd for å lekke?
aldri sjelden av og til ofte alltid
10.  Unngår du steder og situasjoner hvor du vet at toilett ikke er lett tilgjengelig?
aldri sjelden av og til ofte alltid
11. Er ditt seksualliv blitt påvirket av ditt lekkasjeproblem?
blitt mye bedre blitt litt bedre
ikke aktuelt
uforandret blitt litt verre blitt mye verre
12.
ja nei ikke aktuelt
ja nei ikke aktuelt
ja nei ikke aktuelt
ja nei
Skriv ikke her. Fylles ut av lege.
utreder nummer
2.11.05.10
Norsk kvinnelig inkontinensregister  © S. Kulseng-Hanssen
antall tidligere inkontinensoperasjoner
Kryss av ja, nei eller ikke aktuelt for alle spørsmålene under  punkt 12
Vennligst kontroller at du har besvart alle spørsmål som skal besvares
andre komplikasjoner
lekkasje ved 24 timers bleietest gram
lekkasje stresstest gram
maksimum flow ml/sec
max. lukketrykk cm vann
vekt i kilo
høyde i cm
operatørnummer
operasjons nummer
NUGG pasientnummer ved forrige operasjon
operasjonens navn (8, 10 , 11, 12)
inkontinens- og prolapsoperasjon samtidigja nei
operert for inkontinens ved vår avdeling tidl.ja nei
Påvirker din urinlekkasje
dine ferier?
 ditt familieliv?
ditt sosiale liv (å gå ut, å  treffe venner)?
din nattesøvn?
operasjonsdato
. .
antall vannlatinger pr 24 timer
gjennomsnitt vannlatingsvolum ml
resturin ml
komplikasjon ja nei
blæreperforasjon ja nei
hematom > 4 cm Ø ja nei
overfladisk sårinfeksjon ja nei
dyp sårinfeksjon ja nei
kateter > 1 uke ja nei
varighet smerter
ingen
mindre enn 14 dager
opp til 3 mnd
mer enn 3 mnd
tarmperforasjon ja nei
karskade ja nei
kateter > 1 mnd ja nei
smerte 0 til 10
blødning > 500 ml ja nei
urethraskade ja nei
annen skade ja nei
dato slynge klippet
. .
justere bånd operativt ja nei
dato for avbrudt og ikke fullført operasjon
. .
Draft
